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Prof Pat O’Mahony, Chairman 
I am pleased to introduce HIQA’s 2019 Annual Report. This 
document outlines how HIQA fulfilled the first year of its 2019–2021 
Corporate Plan. 
Our Corporate Plan outlines a clear and ambitious direction for the 
organisation over the three years, consistent with our growing remit, 
and Government policy, and is aligned to the objectives set out in the 
Department of Health’s statement of strategy. 
In 2019, we took strides towards meeting these aims. For example, 
by promoting sustainable improvements through the development of
national standards and guidance. The Minister for Health approved and 
launched the National Standards for Adult Safeguarding last year, while 
we also published Guidance on a Human Rights-Based Approach in Health 
and Social Care Services in November. Together, these documents 
support services to protect people and promote their rights. 
We also continued to drive quality improvement through our regulation 
and inspection activity. We carried out over 1,600 inspections of health 
and social care services last year; monitoring and regulating the quality
and safety of care. We saw our remit expand with responsibility for
the regulation of medical exposure to ionising radiation. During 2019, 
significant preparation took place to enable us to carry out this work. 
2019 also saw the expansion of the National Care Experience 
Programme from inpatient experience in acute hospitals to include 
a survey of women’s experiences of maternity care, with plans to 
survey women who gave birth in October or November 2019 in early
2020. We also progressed plans to expand the programme in 2020 to 
conduct surveys in other areas of care provision.  
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A key objective for HIQA is enabling decision-making based on evidence 
and research. During the year, we increased our focus on providing 
advice, evidence and information to ensure informed decisions are made 
about our health and social care sector. 
In 2019, our work in assessing new health technologies has provided 
essential advice on investment in testing at the point of care for
antibiotic prescribing, the HIV-prevention intervention PrEP, and TAVI, 
an alternative to surgical aortic valve replacement. Our HRB-CICER and 
Evidence for Policy teams continue to deliver high-quality evidence bases 
to inform national clinical guidelines and other key policy decisions. 
We worked on improving the quality of health information and data 
collected and used by health and social care services. We continued 
to support the introduction of eHealth in Ireland through developing 
international reviews, recommendations to the Minister and national 
standards on the information requirements to rollout the projects. 
While this report reflects our work in 2019, the organisational skills and 
knowledge of the areas we work in will be vital in meeting the challenges 
of 2020, both through working relationships and understanding of issues, 
as well as in our overall response. I would like to thank all of our staff
for their commitment in 2019, and for carrying out our work in line with 
HIQA’s missions and values. I would also like to thank the members of
















Chief Inspector of Social 
Services1 
HIQA was established to drive high-quality and safe care for people 
using Ireland’s health and social care services. We do this through 
the regulation of social services and inspecting and monitoring public 
health services and children’s social services. 
The regulation of designated centres is a key mechanism that aims 
to provide assurance to the public about the safety and quality of a 
service. The Chief Inspector of Social Services within HIQA regulates 
residential centres for older persons (also known as nursing homes), 
people with disabilities and special care units for children. Regulation 
involves registering, inspecting and monitoring, and receipt of
information. 
The Chief Inspector maintains a register of designated centres which 
have been inspected and deemed to meet the regulatory compliance 
required for registration. While registration ensures that designated 
centres provide safe services by controlling who can or who cannot 
operate a centre. Inspection activity is also a key component of
regulation to ensure services are safe. The Chief Inspector assesses 
whether a provider will comply or is complying with the regulations2 
and standards,3 prioritising the protection and safeguarding of residents 
to ensure that residents receive a high standard of care. 
The receipt and review of information is a vital component in the 
regulation of services. We receive, analyse and risk assess information 
from a range of sources. Such information, which may be in the form 
of statutory notifications or unsolicited information, is used to identify
potentially harmful events that have impacted on the health, safety and 
wellbeing of people using services. 
1 This annual report constitutes the report of the Chief Inspector of Social Services, as 
outlined in the Health Act 2007. 
2 Health Act 2007 (as amended) 
3 National standards as available on www.hiqa.ie. 
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During 2019, our inspectors carried out over 1,600 inspections and 
spoke to an even larger number of people who use services. Our
findings show that many people are receiving a good quality service. 
This is reflected in the positive feedback we hear while on inspection, 
in our inspection reports and in the overall trend of improved 
compliance. However, there remains a significant number of children 
and adults who are not receiving a service appropriate to their needs 
and preferences. 
Our priority is to continue to safeguard these people and drive 
improvements for everyone who accesses health and social services 
in Ireland. 
Overview reports of our work during 2019 in services for children, 
older persons and people with disabilities, and healthcare services will 
be published in 2020. 
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The Health Information and Quality Authority (HIQA) is the independent authority
established in 2007 to drive high-quality and safe care for people using health 
and social care services in Ireland. HIQA’s role is to develop standards, inspect 
and review health and social care services and support informed decisions on how
services are delivered. 
This Annual Report outlines the work of HIQA from 1 January to 31 December
2019, in keeping with the statutory requirements of the Health Act 2007, and 
includes HIQA’s arrangements for implementing and maintaining adherence to 
the Code of Governance for public bodies. It also includes the Report of the Chief
Inspector of Social Services and the Annual Governance and Compliance Report, as 
required by the Health Act 2007, and our annual financial statements. 
1.2 Our mandate and activities 
Our mandate extends across a specified range of public, private and voluntary sector
services. Reporting to the Minister for Health and engaging with the Minister for
Children and Youth Affairs, HIQA has responsibility for the following: 
■ Setting standards for health and social care services – Developing person-
centred standards and guidance, based on evidence and international best 
practice, for health and social care services in Ireland. 
■ Regulating social care services – The Chief Inspector within HIQA is 
responsible for registering and inspecting residential services for older people 
and people with a disability, and children’s special care units. 
■ Regulating health services – Regulating medical exposure to ionising radiation. 
■ Monitoring services – Monitoring the safety and quality of health services and 
children’s social services, and investigating as necessary serious concerns about 
the health and welfare of people who use these services. 
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■ Health technology assessment – Evaluating the clinical and cost-effectiveness 
of health programmes, policies, medicines, medical equipment, diagnostic and 
surgical techniques, health promotion and protection activities, and providing 
advice to enable the best use of resources and the best outcomes for people 
who use our health service. 
■ Health information – Advising on the efficient and secure collection and 
sharing of health information, setting standards, evaluating information 
resources and publishing information on the delivery and performance of
Ireland’s health and social care services. 
■ National Care Experience Programme – Carrying out national service-user
experience surveys across a range of health services, in conjunction with the 
Department of Health and the HSE. 
The statutory functions that provide the basis for HIQA’s work are outlined in the 
Health Act 2007, the Child Care Acts 1991 and 2001 (as amended), the Children 
Act 2001, the Education for Persons with Special Educational Needs Act 2004, and 
the Disability Act 2005. 
12 
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Governance and management 
2.1 Our Board 
The Board is the governing body of HIQA and was first established on 15 May
2007. The Board is responsible for the appropriate governance of the organisation, 
ensuring effective systems of internal control, statutory and operational compliance 
and risk management. These provide the essential elements of effective corporate 
governance and compliance. 
Membership of the Board is made up of a Chairperson and 11 non-executive 
directors who have been appointed by the Minister for Health. The Board members 
have specific experience and expertise in matters connected with HIQA’s functions, 
and come from a range of health and social care professions and industries. 






Former Chairman of the 
Management Board of
the European Medicines 
Agency. Former Deputy
Secretary General and 
Head of Governance 
and Performance at the 
Department of Health. 
Former Chief Executive 





CEO of the Medical 
Council of Ireland. Former
Assistant National 
Director with the HSE 
and CEO of the Crisis 
Pregnancy Agency. 
Lynsey Perdisatt 
Senior HR professional 
having worked in both 
the private and public 
sector, with significant 
experience in employee 
relations, industrial 
relations and change 
management. 
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of Beaumont Hospital. 
Former Chief Executive 
of the Health Research 
Board and former
Executive Management 
Team member of IDA
Ireland. 
Dr Jim Kiely
Vice Chair of the Board 
of Tallaght University
Hospital and a member
of the Commencement, 
Transition and Integration 
Committee for the 
National Children’s 
Hospital. Former Chief
Medical Officer in the 




CEO of Cork University
Hospital. Served on 
various national advisory
and consultancy bodies 
for the Department of
Health. Former board 
member of Irish Blood 
Transfusion Board, 
Road Safety Authority




in health service 
development and 
delivery, and in research 
into health policy and 
management in the UK 
and Ireland. Member of
the Roster of Experts 
appointed to support 
WHO Digital Health 
Technical Advisory Group. 
Paula Kilbane 
Formerly CEO of Eastern 
Health and Social Services 
Board in Northern Ireland 
and Director of Public 
Health of the Southern 
Health Board Northern 
Ireland. Currently a 
director of a number of
boards in the private, 
public and charitable 
sectors. 
Molly Buckley
Public health nurse. 
Equality and disability
rights activist. Former





Chairperson of Rights 
for the Elderly Voluntary
Housing Association Ltd. 
Chairperson of Power
4Good Ireland Ltd, 
working with people with 
a disability in Zambia. 
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Solicitor. Director of the 
Irish League of Credit 
Unions. Chairman of
the Irish Auditing and 
Accounting Supervisory
Authority. Commissioner




with the Association 
of Chartered Certified 
Accountants who worked 
with AIB Business 
Banking and is now a 
director with BDO.  
The following members stood down from the Board in 2019: 
Judith Foley
Acting Chief Education 
Officer, Education 
Department of An 







worked in children’s 
health and social 
service in the UK and 
Ireland. Board member
and Commissioner
of the Commission 
to Inquire into Child 
Abuse. Chairperson of
Mountjoy Prison Visiting 
Committee. Committee 
member of the 
Pharmaceutical Society
of Ireland and of the 
Health and Social Care 
Professionals Council 
regulatory body, CORU.  
Dr Deirdre Madden 
Professor of Law at 
University College 
Cork. Member of the 
Health and Social Care 
Professionals Council, 
CORU and former
member of the Medical 
Council of Ireland. 
Chaired the Commission 
on Patient Safety and 
Quality Assurance. 
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2.2 Board meetings 
Under the Health Act 2007 the Board is required to meet six times annually. In total, 
HIQA’s Board met 10 times during 2019 to progress various significant matters (see 
Chapter 5 for more detail on our Board activities in 2019). 
2.3 Board committees 
Four Board committees support the activities of the Board in governing HIQA: 
■ Regulation Committee oversees the effectiveness, governance, compliance 
and controls around the delivery of HIQA’s regulatory functions. 
■ Audit, Risk and Governance Committee supports the Board in relation to 
its responsibilities for issues of risk, control and governance and associated 
assurance. The Audit, Risk and Governance Committee is independent from 
the financial management of the organisation. In particular, the committee 
ensures that the internal control systems, including audit activities, are 
monitored actively and independently. The committee reports to the Board 
after each meeting, and formally in writing annually. 
■ Standards, Information, Research and Technology Committee oversees 
the governance arrangements, including compliance and controls, for the 
functions of standards development, health information and health technology
assessment functions. 
■ Resources Oversight Committee monitors the resource requirements of
HIQA to ensure that they are aligned with HIQA’s corporate strategy, including 
oversight of resource-related risks. In addition, it oversees organisational needs 
and managerial performance. 
17 








2.4 Executive Management Team 
HIQA’s organisational structure reflects the core functions and activities of Regulation, 
Health Technology Assessment and Health Information and Standards, together with 
the support services that enable us to achieve our corporate objectives: the Chief
Executive’s Office, Operations, Information, and Communications and Stakeholder
Engagement. The organisation is led by the Executive Management Team which is 
supported by other senior managers who are responsible for our business functions. 
The membership of HIQA’s Executive Management Team during 2019 included: 
Phelim Quinn 
Chief Executive 
Dr Máirín Ryan 





Director of Regulation 
and Chief Inspector of
Social Services 
Rachel Flynn 




Acting Chief Operations 
Officer
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2.5 Corporate governance 
The Board of HIQA is responsible for HIQA’s system of internal controls and for
reviewing the effectiveness of these controls, including financial, operational and 
compliance controls, and risk management. 
To deliver on this responsibility, the Audit, Risk and Governance Committee takes an 
active role in coordinating the assurances derived from various sources, such as: 
■ internal audit work 
■ audit by Comptroller and Auditor General 
■ risk management 
■ review of financial controls 
■ review of financial statements. 
In addition: 
■ The Executive Management Team provides an annual assurance statement 
to the Board which sets out the controls covering the totality of HIQA’s 
functions. 
■ Regular corporate performance reports are provided to the Board, including 
corporate risks. 
■ The Chief Executive provides a report at each meeting of the Board. 
■ The four Board subcommittees report to the Board. 
Compliance with the Code of Practice for the Governance of State 
Bodies 
HIQA has a Code of Governance, Code of Business Conduct and related governance 
policies and procedures to ensure its compliance with the revised Code of Practice 
for the Governance of State Bodies. 
HIQA holds the SWiFT 3000 Governance Standard from the National Standards 
Authority of Ireland.  
A detailed Annual Governance and Compliance report is included with the annual 
financial statements for 2019. 
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3.1 Mission statement, vision and values 
Mission statement
Working to improve health and social care services for people in Ireland.
Our  vision  
We work to protect and safeguard service users 
We work to improve the quality of health and 
social care services 
We provide advice, evidence and information to 









We provide a reliable source of information for
the public and our stakeholders 




Being open and 
accountable 
HIQA’s values: In practice, this means we will: 
put the needs, voices, rights and protection of people who
use health and social care services at the centre of our work. 






be fair and objective in our dealings with people and 
organisations. 
communicate the nature and outcomes of our work and 
accept full responsibility for our actions. 
continually improve the quality of our work and use the 
best available evidence. 
listen to and work with those funding, planning, providing 
and using health and social care services. 
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3.2 Strategic objectives 
HIQA’s Corporate Plan 2019–2021 sets out the framework and strategic objectives 
that enable us to meet existing and new obligations. This plan outlines the direction 














for health and 
social care 
service 
Advise on the 
effective use 
of information 
in health and 
social care 














These objectives, priorities and commitments, articulated within the Corporate Plan, 
are met through objectives set out in our annual business plan. Progress in achieving 
these objectives is summarised in the next chapter. 
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2019 IN NUMBERS 
202 
RESPONSES 










































Our 2019 Business Plan sets out an ambitious agenda to 
achieve our strategic objectives in the first year of our 
Corporate Plan 2019—2021. This chapter sets out how HIQA 
has met these objectives, while also fulfilling our vision. 
24 
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          4.1 Safer Services 
Patient safety and safeguarding  
Safeguarding people who may be vulnerable is a priority for HIQA. We do this 
by setting national standards to ensure everyone who uses services is safe and 
protected, and to ensure services and the staff who work in them can drive 
improvements. We also safeguard people by regulating nursing homes, residential 
services for people with disabilities, special care units and medical exposures to 
ionising radiation. We also monitor and inspect public healthcare services and 
children’s services to ensure people are receiving a safe, high-quality service. This 
section outlines how we worked to make services safer in 2019. 
National Standards for Adult Safeguarding 
In September 2019, the Minister for Health approved the National Standards for Adult 
Safeguarding, jointly developed by HIQA and the Mental Health Commission. The 
standards recognise the right of every adult to be safe and to live a life free from 
harm. Any adult can go through a period of risk and need care and support. This care 
and support should be balanced and proportionate to manage or mitigate this risk, 
in order for the person to live a safe and fulfilling life. The National Standards for Adult 
Safeguarding focus attention on the area of safeguarding and provides a detailed 
framework to drive improvement in best practice in the area. 
Having these national standards in place allows for a consistent approach to 
preventing and responding to harm if it does occur. The standards outline a way
of working for health and social care services and support the development of a 
culture where safeguarding is embedded into practice rather than being viewed as 
a separate activity. By describing what adult safeguarding is and clearly setting out 
how staff can prevent and respond to harm, the standards aim to help health and 
social care services reduce the risk of harm; promote people’s rights, health and 
wellbeing; and empower people to protect themselves. 
The standards also support the development of integrated working in and between 
the range of health and social care services that people interact with, recognising 
that people may be at increased risk of harm when they are using multiple services 
or when they are moving from one service to another. 
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The standards aim to support people who use health and social care services to 
understand what safeguarding is and promote awareness of their right to be safe 
when they are using services. However, HIQA believes that a system-wide approach 
to addressing safeguarding requires policy and legislation to also be in place. We 
look forward to the development by the Department of Health of an overarching 
national adult safeguarding policy and underpinning legislation for the health sector, 
and the revision of the HSE’s national operational adult safeguarding policy. 
Regulation of social services 
Regulation of designated centres encompasses registration, inspection and the 
receipt of information. Registration of a designated centre means that the Chief
Inspector has assessed a centre as compliant with the regulations at the time of
registration, therefore deeming the provider able to provide services. 
The Chief Inspector maintains a register of designated centres which have been 
inspected and deemed to meet the regulatory compliance required for registration. 
While registration ensures that designated centres provide safe services by
controlling who can or who cannot operate a centre, inspection activity is also a key
component of regulation to ensure services are safe. The Chief Inspector assesses 
whether a provider will comply or is complying with the regulations and standards, 
prioritising the protection and safeguarding of residents ensuring that they receive a 
high standard of care. 
The receipt and review of information is a vital component in the regulation of
services. HIQA receives, analyses and risk assesses information from a range of
sources. Such information, which may be in the form of statutory notifications or
unsolicited information, is used to identify potentially harmful events that have 
impacted on the health, safety and wellbeing of people using services. In 2019, we 
were awarded a grant from the Health Research Board to assess this information. 
See Section 4.3. 
Regulation of nursing homes 
Registration 
As of 31 December 2019, there were 585 nursing homes in Ireland, comprising 
31,969 beds. This is a net increase of four nursing homes and 718 beds since 31 
December 2018. 
The continued growth in the nursing home sector is reflected in the differential 
between the number of nursing homes closing and the number of new or enlarged 
nursing homes. In 2019, six nursing homes (providing 146 beds) closed and were 
removed from the register. Five homes voluntarily ceased operating, while an 
application to renew registration for a sixth was refused. In contrast, additional 
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nursing home beds became available when 14 centres increased the number of beds 
in their existing centres and 104 new nursing homes were registered. These changes 
have provided 870 additional nursing home beds.   
In addition to the above registrations, extensions and closures, 22 centres changed 
ownership when a new legal entity applied to become the registered provider of an 
existing centre. Many of these developments reflect changes in the profile of nursing 
home ownership with existing national registered providers exiting the market and 
new international providers entering. 
The profile of nursing home ownership remains largely unchanged in the last 12 
months with the vast majority of nursing homes owned and operated by private 
providers: 
■ Private providers were the registered owners of 76% (443) of nursing homes. 
■ The Health Service Executive (HSE) was the registered provider of 21% (122) 
of nursing homes. 
■ HSE-funded bodies5 were the registered owners of 3% (20) of nursing homes. 




n	Health Service Executive (HSE) (Public) 
n	HSE-funded bodies under Sections 38 and 
39 of the Health Act 2004 
n	Private providers 
At the end of 2019, there were 115 nursing homes with one or more restrictive 
conditions6 attached to their registration. 
4 One of the 10 newly registered nursing homes is owned and operated by the HSE (23 beds) while the other nine (847 
beds) are privately owned and operated. 
5 Section 38 of the Health Act 2004 states that the HSE can have an arrangement with a person to provide a health or
social care service on behalf of the HSE. Section 39 of the Health Act 2004 states that the HSE can provide assistance 
to any person or body providing a similar service to the HSE. 
6 A condition of registration sets the parameters by which a provider must operate, or restricts what services a provider
can provide in a designated centre. 
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In 2019, we carried out 5477 inspections of nursing homes; 67% of these 
inspections were unannounced. 
Figure 2: Percentage of announced and unannounced inspections of nursing 





Inspectors of social services carried out 402 inspections of 344 nursing homes to 
assess whether registered providers were complying with regulations and ensuring 
the safety and care and welfare of residents. 
Most nursing homes will be inspected at least once a year; however, concerns about 
the care and welfare of residents may require an increase in inspection activity in a 
small number of nursing homes. In 2019, nine nursing homes were inspected three 
or more times.   
There is a high level of regulatory8 compliance among providers of nursing homes 
with the majority of providers focused on ensuring that they deliver a quality and 
safe service which supports residents to enjoy their lives. 
The findings of our inspections in 2019 demonstrate that the majority of nursing 
home providers maintain a high level of regulatory compliance.   
7 The total number of inspections includes regulatory compliance inspections and thematic inspections. 
8 Health Act 2007 (Care and Welfare of Residents in Designated Centres for Older People) Regulations 2013 Health Act
2007 (Registration of Designated Centres for Older People) Regulations 2015. 
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Figure 3: Compliance against care and welfare regulations in nursing homes in 
2019 
72.4% 16.6% 11.0% 
n	Compliant    n	Substantially compliant   n	Not compliant 
However, we have concerns about the measures some providers have in place to 
ensure that residents are protected from the risk of fire. One in three (33%) nursing 
homes were not compliant with the regulation underpinning fire safety and fire 
evacuation procedures. This is not acceptable.  
Furthermore, providers who had not yet addressed the physical limitations of their 
premises continued to struggle to achieve compliance with other regulations such 
as those related to residents’ rights, access to their possessions, the management 
of risk and the control of infection. We found 34% of nursing homes were non-
compliant with regulation 17 (premises), indicating that a number of providers 
must still take action to provide premises that comply with the regulations by 31 
December 2021.9 
Receipt of information 
Providers or persons in charge are required to submit notifications of significant 
events that occur in a centre within three days, and to notify the Chief Inspector of 
other specific matters in the centre on a quarterly basis. These notifications are risk 
assessed and inform our regulatory actions. 
During 2019, we received 14,792 notifications from nursing homes, including: 
■ 5,633 monitoring notifications10 
■ 2,237 registration notifications11 
■ 6,737 quarterly notifications12 
■ 185 others. 
9 In 2016, the Health Act 2007 (Care and Welfare of Residents in Designated Centres for Older People) Regulation 
2013 was amended through Statutory Instrument (SI) 293, thereby allowing registered providers until the end of 
2021 to demonstrate compliance with Regulation 17 and Schedule 6 of the 2013 care and welfare regulations. 
10 Notifications in line with the care and welfare regulations. 
11 Notifications about changes to details relating to the information published on HIQA’s register. 
12 Notification of any occasion where a restraint was used, any occasion of fire alarm activation, any recurring pattern 
of theft or burglary, any injury to a resident that did not require notification within three days or any death(s) other 

















This represents an overall increase of 2,736 notifications since 2018, with the most 
notable increase seen in registration notifications. 
During 2019, we received unsolicited information from members of the public who 
had a concern or an issue with the care provided to residents living in a nursing 
home. We used this information to drive better care in these centres. During 2019, 
we received 711 pieces of unsolicited information relating to nursing homes, an 8% 
reduction on the number received in 2018. 
Regulation of centres for people with a disability 
Registration 
There continued to be a growth in the number of centres for people with a disability
in 2019. By 31 December 2019, there were 1,268 such centres, a net increase of 85 
centres during the year. These centres provided 9,064 residential places for people 
with disabilities, an increase of 170 on the number of places at the end of 2018. 
Designated centres for people with disabilities are provided by a number of different 
bodies. The funding arrangements for these centres changed little in 2019, with the 
majority of centres either being directly provided by the State through the Health 
Service Executive (HSE) or provided by organisations funded by the HSE. 
Figure 4: Number of registered designated centres for people with disabilities by




n	Health Act 2004 Section 38 Arrangement 
n	Health Act 2004 Section 39 Assistance 
n	The Health Service Executive 
13 Section 38 of the Health Act 2004 states that the HSE can have an arrangement with a person to provide a health 
or personal social service on behalf of the HSE. Section 39 of the Health Act 2004 states that the HSE can provide 
assistance to any person or body providing a similar service to the HSE. 
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The HSE directly provided 1,116 (12.3%) residential places, with 5,109 places 
(56.4%) provided by organisations funded through Section 38, and 2,839 residential 
places (31.3%) provided through Section 39 assistance. The majority of residential 
places (8,457) were for adults with disabilities, while 347 places were specifically
for children, and 260 places were for either children or adults. Most of these mixed 
centres were respite services which provided breaks to adults and 
children separately. 
Figure 5: Number of registered designated centres for people with disabilities by
centre type at 31 December 2019 
80 41 
1,147 
n	Designated Centres for Disabilities (Adults) 
n	Designated Centres for Disabilities (Children) 
n	Designated Centres for Disabilities (Adults 
and Children) 
During 2019, there was an overall increase in the number of centres, many of
which were new centres for residents who were formerly accommodated in larger
congregated settings or for people in the community who had an emergency
requirement for residential services. 
A congregated setting is defined as a residential service where 10 or more people 
are accommodated together.14 There continues to be a significant number of people 
with disabilities living in congregated settings. 
Of the 9,064 registered residential places at the end of 2019, 2,914 of these were 
located in congregated settings, either in campus-based settings or in standalone 
houses with 10 or more people. 
This figure of 2,914 is further broken down as follows: 
■ 2,368 registered places in campus-based settings 
■ 546 registered places in large standalone residential houses. 
14 Time to move on from congregated settings - A strategy for community inclusion. Dublin, Health Service Executive; 
2011. 
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Another issue for consideration is the number of centres with additional, restrictive 
conditions of registration. Some centres were not fully compliant with the 
requirements of the Health Act 2007 at the time of registration. Where the provider 
has demonstrated that action is being taken to address the outstanding issues, 
the Chief Inspector may decide to register the centre with additional restrictive 
conditions. This means that compliance with the particular condition becomes a legal 
obligation under the terms of the registration for the centre. At the end of 2019, 
there were 136 centres with one or more restrictive conditions attached to their 
registration.  
Figure 6: Registered designated centres for people with disabilities with or 
without restrictive conditions of registration 
1,132 136 
n	Centres with no restrictive conditions attached to registration 
n	Centres with restrictive conditions attached to registration 
Inspections 
In 2019, we carried out 1,016 inspections in 895 centres for people with disabilities 
to ensure that the service being provided was safe and of a good quality. In all, 88% 
of all designated centres for people for disabilities were visited by inspectors. 
In 2019, 240 centres had inspections for the purposes of informing a registration 
renewal decision. We carried out 715 inspections to assess whether registered 
providers were complying with regulations, and in so doing ensuring the change 
to safety, care and welfare of residents. In addition, 54 thematic inspections were 
completed to drive improvement in the area of restrictive practice following a 
programme of engagement with providers on the subject. See section 4.2 for more 
information on this. 
Inspections can be announced or unannounced and may take place at any time of 
day or night. Of the 1,016 inspections completed, 70% were unannounced while 
30% were announced. For some residents, the unannounced arrival of visitors to 
their home can be a difficult experience. In these circumstances, inspectors may give 
advance notice of the inspection or modify the timings of inspections in line with 
residents’ or providers’ feedback. 
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Figure 7: Percentage of announced and unannounced inspections of designated 
centres for people with disabilities carried out in 2019 
70% 
30% 
n	676 unannounced inspections 
n	286 announced inspections 
Of the 895 centres visited in 2019, 777 received one inspection. This indicates 
that these centres had a good level of compliance and that, where there were non-
compliances, the provider responded appropriately. Approximately 13% of all centres 
(115 centres) required two inspections to monitor compliance during the year, while 
just three centres required three or more inspections. 
This figure compares favourably with 2018 when seven centres required three or
more visits. This is reflective of improving levels of compliance in the sector.  
Overall, there continues to be improvement in compliance levels, particularly in 
relation to key regulations that impact on the safety and quality of life of residents. 
In 2019, HIQA published Five Years of Regulation in Centres for People with Disabilities
which set out the changes in the quality and safety of services and the compliance 
levels in key regulations over the first five years of regulation. During our inspections 
in 2019, we found that there continued to be improvements in these key areas, with 
the exception of congregated settings, where we found that there were higher levels 
of non-compliance. 
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Figure 8: Compliance against key regulations in all designated centres for people 
with disabilities in 2019  

























Risk managment procedures 
Our inspection findings for 2019 highlight the higher level of non-compliance in key
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Figure 9: Compliance against key regulations in congregated settings in 2019  
























Risk managment procedures 
As Figure 9 shows, congregated settings had over twice the number of non-
compliances in the area of governance and management than the figure for all 
centres (Figure 8). 
HIQA has repeatedly highlighted the importance of ensuring robust governance 
arrangements in centres. Where providers have ensured that centres are managed 
by suitably qualified and experienced personnel, and where providers have good 
audit and oversight arrangements, there has been a positive impact on residents’
quality of life and on the overall compliance levels within the centre. Our 2019 
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findings show that governance arrangements in over a third of congregated settings 
were unsatisfactory and they lagged significantly behind the national average for all 
centres nationally. 
There was also a larger degree of non-compliance in critical areas, such as protecting 
residents from the risk of abuse, ensuring residents’ rights were protected, and 
ensuring that residents were appropriately consulted about their services. These are 
important indicators of residents’ wellbeing. 
Receipt of information 
Providers and persons in charge are required to submit notifications of specific, 
significant events that occur within the centre to us within three days, and about 1
other events in a centre on a quarterly basis. Inspectors then risk assess each 
notification and this information is used in deciding the regulatory action to be taken 
in relation to that centre. 
Inspectors assessed 21,615 notifications from centres for people with disabilities 
in 2019, compared with 18,237 such notifications in 2018. The increase in 2019 
can be partially attributed to an overall increase in the number of registered centres 
during the year. 
Figure 10: Regulatory notifications received from services for people with 




10,304 2,236 9,075 
n	Monitoring notifications 
6000 n	Registration notifications 
4000 n	Other 
2000 
We also received 240 pieces of unsolicited information relating to designated 
centres for people with disabilities. This is information that is shared with us 
by anyone who has a concern about the service being provided to people with 
disabilities in residential centres. 
Inspectors individually review the information and use it in conjunction with other
information about the centre to inform our regulatory actions up to and including 
inspection activity. 
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The concerns submitted in 2019 included those relating to admissions and 
contracts, response to complaints within the centre, residents’ access to their local 
community, general welfare and development, governance and management, health 
and safety, risk management, healthcare, medicines management, residents’ rights, 
premises, safeguarding and safety, social care needs and workforce. 
Monitoring and regulation of children’s services 
Special care units 
Registration 
There are three special care units in Ireland provided by Tusla. They are secure 
(locked) residential centres for children aged 11 to 17 years. Children are placed 
in special care by a court when it has been determined that they require care and 
protection as their behaviour places them at risk. Children placed in special care 
receive therapeutic and educational supports in each unit. 
All three special care units are registered by HIQA until November 2021. 
Figure 11: Compliance against selected regulations related to quality and safety in 
special care units 
n	Compliant    n	Substantially compliant   n	Not compliant 
Regulation 9: Education, individual needs, 
religion, ethnicity, culture and language 
Regulation 8: Health Care 
Regulation 7: Programme of Care 
Regulation 27: Notification of Incidents 
Regulation 25: Risk Management 
Regulation 17: Accommodation 












Within the three-year registration cycle, special care units are monitored by HIQA
to ensure ongoing compliance with the regulations and to promote continual 
improvement. 
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Inspectors carried out monitoring inspections of all three special care units, and one 
further risk-based inspection in 2019. The focus of the monitoring inspections was 
primarily on the regulations related to leadership, governance and management, 
as this was an area which was identified as requiring improvement in 2018. These 
inspections found that there were improved management structures in place and 
this ensured good levels of accountability. There was also a level of stability at 
managerial level, and improved systems in place to manage risk, with managers 
becoming more confident in their use. 
However, improvements were required with regard to finalising national policies 
and procedures; the arrangements in place to monitor and report on the quality
of special care; the need for a more developed and consistent approach to the 
management of allegations; and improvements in the effectiveness of responses to 
children who repeatedly absconded and were at potentially high risk when doing so. 
Furthermore, two special care units could not provide the number of beds for which 
they were registered due to staffing shortages. However, it was evident that special 
care units were beginning to recruit new staff. 
Receipt of information 
In 2019, we received the following notifications from special care units: 
■ 159 monitoring notifications 
■ 17 quarterly notifications 
■ 9 registration notifications. 
Monitoring of children’s social services 
HIQA also monitors non-regulated children’s services to ensure children are 
receiving a safe, high-quality service. 
In 2019, we carried out 47 monitoring inspections across a range of children’s 
services. 
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Figure 12: Inspections of children’s services in 2019 
n	Number of Inspections 
Oberstown Children Detention Campus 
Child Protection and Welfare (Risk based) 
Child Protection and Welfare (Thematic) 
Service area based (foster care and child protection) 
Children’s residential centres 
Placement of Children in Care Regulations 1995 
Statutory foster care 









Tusla social work services for children in residential care 
In 2019, we carried out eight inspections focusing on the statutory duties of the 
Child and Family Agency (Tusla) social workers in monitoring placements for children 
in residential care, in line with the Child Care (Placement of Children in Care) 
Regulations, 1995. These inspections were announced and covered regulations 
22 to 25, which relate to social work case records, care planning, supervision and 
visiting and case reviews of children placed in residential care to ensure that safe 
services were provided to these children. 
Inspections were carried out in two service areas within each of the four Tusla 
regions – the West, the South, Dublin North East, and Dublin Mid-Leinster. 
These inspections found that care planning was generally good for children in 
residential care. Care plan reviews were undertaken in a timely manner across three 
out of four regions. Some areas of improvement in relation to care plans and their
review included the need for timely approval of care plans by the social work team 
leader, and consistency in the quality of information held in care plans. 
Supervision and visiting of children in residential care was generally good and 
records of these visits were held by social workers. Children were visited within 
the time frames set out in the regulations, but also in response to risk or their level 
of need. Although the majority of children placed in residential care at the time of
inspection were allocated a social worker, it was evident that there were periods of
time during their placement when some children did not have a social worker. 
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While each child placed in residential care across the four regions had a case record, 
variation in quality was noted. This related to variation in adherence to time frames 
for updating records, or in consistently holding all information required by the 
regulations. 
Children’s residential centres 
In 2019, we carried out 18 inspections of children’s residential centres run by
Tusla.15 We inspected a representative sample of centres within each Tusla region 
for the purpose of learning and driving continual improvement at local and regional 
levels. Two of the centres inspected were prioritised due to poor findings in 2018, 
specifically, the premises from which the services were being delivered. 
This was the first time the level of compliance with National Standards for Children’s 
Residential Centres (2018) was assessed in these centres. In preparation for children’s 
residential centres becoming designated (regulated) centres as defined under the 
Health Act 2007, our inspections focused on 12 of the 29 standards related to 
leadership, governance and management, and the delivery of needs-based care to 
children in a safe and effective way. 
Overall, these inspections found that children were well cared for, and the majority
experienced nurturing and safe care. Children’s rights were well promoted and 
children who met with inspectors said they were aware of their rights and were 
encouraged and supported to exercise them. There was a minority of children who 
had complex needs which could not be met within the centres inspected and, for
some, onward placements which could meet these needs were difficult to source. 
This meant that for some children, their experience of care was, at times, neither
safe nor pleasant. In these circumstances, HIQA liaised with both centre managers 
and Tusla social workers and managers to ensure all necessary measures were taken 
to safeguard these children and those who shared placements with them. 
Oberstown Children Detention Campus 
The 2019 inspection of Oberstown Children Detention Campus found that 
young people were provided with a good standard of care, and it was evident that 
improvements had been made in the quality of their lives on campus. Young people 
told inspectors that they were treated fairly and were given opportunities to resolve 
issues or challenges as they arose. They played an active role in the placement 
planning process and were supported to develop their understanding of risk-taking 
behaviours. They knew how to make a complaint and told inspectors that they felt 
listened to when issues arose for them. 
15 The number of Tusla provided children’s residential centres fluctuated between 36 and 39 in 2019. 
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Restrictive procedures, which involve high-risk interventions such as physical 
restraint or the use of single separation, are not uncommon in places of detention 
for young people, and their seriousness cannot be underestimated. Although 
reduced, the use of restrictive practices remained significant in Oberstown. 
However, the commitment to promote the least restrictive living environment for
young people was evident in the everyday opportunities provided to them. 
There was a concerted effort by Oberstown to continuously improve the quality
and delivery of offending behaviour programmes to young people. There were five 
specific young people’s programmes being delivered on campus aimed at reducing 
offending behaviour and ensuring young people’s time spent in Oberstown was 
effective at achieving best outcomes for them. 
Since the last inspection, there was a significant improvement in the range and 
frequency of evidence-based offending behaviour programmes for young people and 
it was encouraging to see that their engagement in these programmes was expected 
and promoted. All young people who spoke with inspectors were aware of the 
programmes available to them to help address their offending behaviour. To further
this progress, improvements were required to introduce programmes which targeted 
young people’s tendencies towards specific types of offending behaviour.  
Risk-based inspections 
Four risk-based inspections were carried out in children’s services during 2019 to 
ensure children were safe. At the time of inspections, these four service areas had 
substantial numbers of children waiting for a service, including children classified by
Tusla as being of high priority. 
While there were some examples of good practice, in all four service areas the 
governance arrangements in place required improvement to ensure the consistent 
provision of a safe and timely child protection and welfare service. 
Common areas that required improvement across all four service areas included: 
■ sharing learning throughout Tusla 
■ the consistent implementation of policies, procedures and standard business 
process 
■ management oversight of staff including supervision 
■ consistent use of caseload management systems 
■ the identification of risks and their management 
■ better developed quality assurance systems. 
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In 2019, all four service areas provided action plans to address the specific non-
compliances identified by the inspections.  
Monitoring and regulation of healthcare services 
In the healthcare setting, our remit predominately extends to monitoring public 
acute hospitals against national standards. Such monitoring includes onsite 
inspections, and we publish the findings and recommendations from our work on 
www.hiqa.ie. In addition, HIQA also has a remit to conduct statutory investigations 
into services where serious patient safety concerns may exist. However, while 
HIQA may make recommendations, these are non-binding. HIQA does not have 
enforcement powers to support this area of our work. 
Medical exposures to ionising radiation 
In January 2019, we began regulating medical exposures to ionising radiation when 
the EU Council Directive 2013/59/Euratom was transposed into Irish law, giving 
HIQA regulatory powers in healthcare services for the first time. HIQA is now the 
Competent Authority in the area of medical exposures to ionising radiation. This role 
requires us to regulate healthcare services across both the public and private sector
and, in doing so, protect patients from risks associated with exposures to ionising 
radiation for medical treatment, such as in the case of X-ray or CT scans. 
In 2019, we undertook preparatory work, such as recruiting an inspection team, 
developing ICT systems, establishing an inspection methodology and providing 
guidance to healthcare providers around our new role. 
We have also been working collaboratively with the Environmental Protection 
Agency (EPA) who regulate non-patient ionising radiation exposures – and a 
memorandum of understanding between the two agencies was published in 
early 2020. 
Providers of medical exposure to ionising radiation, known as undertakings, 
are required to register with us. During 2019, we received 1,254 notifications 
confirming the presence of 1,650 individual sites to be regulated as undertakings 
under this new legislation.  
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Figure 13: Ionising radiation services by service type 
1,498 2,23693 59
     Hospitals    	Dentists  	 Others 
In late 2019, we issued a self-assessment tool to the 211 healthcare providers who 
provide higher levels of ionising radiation to patients as part of their treatment. We 
began to inspect hospitals in November 2019, with six inspections conducted by the 
end of the year. 
As the new Competent Authority in the area of medical exposures to ionising 
radiation, HIQA is required to fulfil a number of roles which complement its 
inspection function to improve the quality and safety of services. One such role 
is the receipt and national oversight of notifications around serious incidents that 
occur related to the accidental or unintended exposures to ionising radiation. We 
established a system of monitoring in January 2019, with 68 such notifications 
received by the end of 2019. 
In 2019, we also began work, with the assistance of an external advisory group, 
to advance the conduct of a national survey of diagnostic reference levels for
certain procedures.16 The collation, analysis and dissemination of findings from 
this exercise are intended to better inform providers of services in their efforts to 
optimise radiation exposure levels for patients, and ensure that dosing is as low as is 
reasonable to achieve imaging without compromising the quality. This survey, which 
is required of HIQA under legislation, will begin in 2020. 
16 A diagnostic reference level (DRL) is a dose level that is set for typical diagnostic and interventional radiological 
procedures. It is used as a tool for service providers to ensure that medical exposures are optimised and each dose 
received by service users is kept as low as possible. 
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         4.2 Better Care
Improving the quality of care 
We aim to make health and social care better for the people who use and access 
these services. Our Corporate Plan 2019–2021 sets out a commitment to drive 
improvements in the quality of care provided to people who use health and social 
care services. We do this by: 
■ developing guidance and supports to improve the quality of care 
■ carrying out thematic inspections to drive quality improvement 
■ conducting the National Care Experience Programme. 
Guidance on a Human Rights-based Approach in Health and Social 
Care Services 
People should expect that their human rights will be promoted and protected at all 
times, including when they require the care and support of health and social care 
services. While HIQA’s inspections have identified good practice in upholding human 
rights in some services, there is limited knowledge and understanding among other
practitioners, and among people using services, on how human rights principles 
apply in health and social care. 
During 2019, we published Guidance on a Human Rights-based Approach in Health 
and Social Care Services to support services and the staff who work in them to 
implement the principles of human rights in their day-to-day work. The guidance 
was developed in conjunction with Safeguarding Ireland, and was part-funded by the 
Irish Human Rights and Equality Commission, under the Human Rights and Equality
Grant Scheme 2017. 
Respect for human rights is implicit within the national standards developed by
HIQA, for example National Standards for Safer Better Healthcare (2012), as well as 
standards for older persons, disability, maternity services, and adult safeguarding. 
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This guidance provides additional support to staff in understanding a human rights-
based approach and implementing the national standards in practice. 
The guidance is based on international best practice and was developed in 
consultation with people who work in health and social care services and the people 
who use these services. It outlines a practical and accessible evidence-based way
of working for front-line health and social care staff. It provides a common language 
and framework to describe a human rights-based approach for the care and support 
of adults. The guidance will also help people using services to understand what 
they should expect from a service that is committed to respecting, protecting, and 
promoting their human rights. 
We have also developed a number of supporting materials to aid understanding and 
implementation of a rights-based approach. This includes frequently asked questions 
about the guidance and how it can help staff in their work, a document outlining the 
legal framework underpinning a human rights-based approach to care and support in 
Ireland, and two decision-making aids to assist staff in their day-to-day practice. 
Thematic inspections 
During 2019, we conducted a number of thematic inspection programmes to drive 
quality improvements in health and social care services. 
Nursing homes 
To improve the quality of care in nursing homes, during 2019 we conducted 
thematic inspections on: 
1. dementia care 
2. restrictive practices 
We carried out 144 thematic inspections, 102 dementia thematic inspections and 
42 restrictive practice thematic inspections.  
Dementia thematic inspections focused on the care provided to residents with 
dementia living in a nursing home. We found that the majority of centres are 
providing good quality care to residents with dementia; however, efforts need to 
continue to ensure that services provided to this most vulnerable group of residents 
continue to improve. 
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Figure 14: Overview of compliance in 2019 dementia thematic inspections  
49.1% 26.8% 19.4% 4.7% 
n	Compliant                             n	Substantially compliant   
n	Non-compliant - moderate n	Non-compliant - major 
In 2019, we commenced a programme of thematic inspections which assessed the 
use of physical and environmental restraint, as well as other forms of restrictive 
practices. This thematic programme assessed compliance against the National 
Standards for Residential Care Settings for Older People in Ireland (2016) for the 
purpose of driving continuous quality improvement for the benefit of those living in 
nursing homes.  
We carried out 42 inspections of this type in nursing homes in 2019 with 
positive findings; 22 centres inspected were found to be compliant17 and 20 were 
substantially compliant.18 This indicates that there is a high level of awareness of 
the need to reduce or eliminate the use of restrictive practices. That said, some 
providers are still working towards balancing residents’ rights to autonomy and 
liberty with the need to ensure the health and safety of residents. While there 
are circumstances where the use of restrictive practices may be unavoidable and 
necessary to ensure a person’s safety or the safety of others, restrictive practices 
are an infringement of a person’s fundamental rights to personal liberty and bodily 
integrity. Providers must ensure that there is appropriate oversight and governance 
of all situations where restraint is used and work to reduce or eliminate the use of 
such restraint.   
Residential services for people with disabilities 
In 2019, we developed a thematic programme of inspections to drive improvements 
in the use of restrictive practices in services, and promote how the National 
Standards for Residential Services for Adults and Children with Disabilities can be used to 
positively impact on the quality of care, and the design of and reduction in the use 
of restrictive practices across the sector. 
17 A finding of compliance indicated that residents enjoyed a good quality of life where the culture, ethos and delivery 
of care were focused on reducing or eliminating the use of restrictive practices. 
18 A finding of substantial compliance indicated that residents received a good, safe service but their quality of life 
would be enhanced by improvements in the management and reduction of restrictive practices. 
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During 2019, we completed 54 restrictive practice thematic inspections across a 
range of residential services for people with a disability. 
In 26 centres, we found that, residents enjoyed a good quality of life where the 
culture, ethos and delivery of care were focused on reducing or eliminating the use 
of restrictive practices. 
In the remaining 28 centres, inspectors found that residents received a good, 
safe service but their quality of life would be enhanced by improvements in the 
management and reduction of restrictive practices. 
These inspections found that effective governance and leadership arrangements 
were essential in ensuring that where restrictive practices were assessed as being 
required, the management of them was underpinned by good human-rights 
principles. 
In addition, many of these services had developed and implemented strategies 
to continually review, reduce and (where possible) eliminate the use of restrictive 
practices. A key factor in achieving this has been good quality staff training and 
education, which has directly influenced a positive staff culture towards the 
reduction of the use of restrictive practices. 
Inspection reports are published on www.hiqa.ie to facilitate the sharing of
information about good practices in the sector. 
Thematic child protection and welfare programme 
HIQA’s child protection and welfare thematic inspection programme, developed in 
2019, aims to promote and support quality improvement in the management of child 
protection and welfare referrals. This programme arose out of a commitment made 
by HIQA in its 2018 Report of the investigation into the management of allegations of
child sexual abuse against adults of concern by the Child and Family Agency (Tusla) upon 
the direction of the Minister for Children and Youth Affairs.
This thematic inspection programme assesses Tusla’s management of all child 
protection and welfare referrals and reports, incorporating screening and preliminary
enquiry of referrals, safety planning and the completion of an initial assessment. 
Services are assessed against seven of the National Standards for the Protection and 
Welfare of Children 2012. 
Following development of a literature review, establishment of an external advisory
group,19 and consultation with parents and children, HIQA published a guidance on 
our assessment and judgment framework for this programme. 
19 The group comprised representatives from the Child and Family Agency (Tusla), the Department of Children and 
Youth Affairs, Barnardos, Epic Trinity College Dublin and Director from Medway Council in the UK. 
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Twelve Tusla service areas completed and returned a self-assessment questionnaire 
to HIQA for review. These questionnaires, along with Tusla’s published metrics 
on unallocated cases, informed the schedule of inspections. To drive quality
improvement in care, we initially focused on service areas that had no or low levels 
of children waiting for a service. 
Commencing in October 2019, we carried out four child protection and welfare 
thematic inspections by the end of 2019. 
The five remaining service areas that are not included in the thematic programme 
are currently subject to service improvement plans developed by Tusla as a 
result of identified risk related to these service areas. Progress in regard to these 
improvement plans will be reviewed by HIQA in early 2020, the findings of which 
will be reflected in further regulatory activity as appropriate.  
Statutory foster care services 
In 2019, we built on our 2017-2018 focused programme of inspection of statutory
foster care services to drive further improvements in care across Tusla’s 17 service 
areas by examining: 
■ whether the child in foster care has an allocated social worker; 
■ the extent to which their needs are assessed prior to or as soon as possible 
after placement; 
■ whether the child’s care is subject to a formal process of planning and review, 
including preparation for leaving care; 
■ that the child is matched with foster carers that can meet his or her needs; 
■ the systems in place to safeguard and protect the child. 
We did this by: 
■ analysing data submitted by service areas and questionnaires completed by
children in care and young people in aftercare; 
■ meeting or speaking with children and young people availing of the aftercare 
service; 
■ interviewing and meeting with the area managers, principal social workers for
the children in care teams, the foster care teams and aftercare managers; 
■ visiting foster care households and meeting with the children residing in these 
homes; 
■ holding separate focus groups with children in care social workers and child 
50 








protection social workers, fostering social workers, team leaders for the long-
term children in care team, aftercare workers and foster carers; 
■ reviewing the relevant sections of children’s case records as they relate to the 
theme of the inspection; 
■ calling parents of children in care, foster carers and children in care. 
During 2019, we completed 11 of these inspections, with the remaining six 
inspections due for completion in 2020. These inspections found that when children 
were allocated a social worker, they received a good quality service and children 
spoke very positively about their social worker. Some areas had significantly high 
numbers of children in care who were not allocated a social worker and, as a result, 
these unallocated children were not receiving the service they should receive, and 
were not being visited in line with regulations.  
Assessments of children were comprehensive, and matching children to foster carers 
who were best placed to meet their needs was evident in the majority of areas; 
however, there were backlogs in completing long-term matching in several areas. 
The aftercare service offered to children was good in many areas, with six of the 11 
areas inspected found to be fully compliant with this standard, and one substantially
compliant. There was excellent practice found in three of the 11 areas, in that 
they met all the requirements of the legislation, and had well-developed aftercare 
services. 
Improvements were required with regard to care planning and review, as several 
areas had backlogs of child in care reviews. Service areas that had high numbers 
of children in care who were not allocated a social worker also had a high number
of care plans that were not up to date. The quality of care plans also varied and 
placement plans were not routinely completed in some areas. 
Following completion of these inspections in 2020, we will publish an overview
report in the interest of improving the overall governance of the foster care service, 
to support and inform the development of common systems and consistency of
practice at both local, regional and national level.  
Healthcare 
In the healthcare setting, HIQA has a remit to monitor public acute hospitals against 
nationally-mandated standards to improve the quality of care being provided. 
In 2019, we conducted a total of 62 inspections across a number of thematic 
monitoring programmes, all of which sought to ensure that hospitals were meeting 
national standards to address internationally recognised areas of patient safety risk. 
These thematic monitoring programmes included a focus on: 
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■ maternity services in 13 maternity units or hospitals 
■ medicines safety in 20 hospitals, and 
■ infection prevention and control in 15 hospitals. 
HIQA’s work in the area of medication safety highlights both strong performing 
hospitals and those that need to do more to better protect patients from the risk 
of potential harm associated with medicines use. In 2019, we focused on ensuring 
hospitals had required measures in place to protect patients from known potential 
risks associated with higher risk medicines. Most hospitals had put in place measures 
to address these specific risk issues, but some hospitals performed less well and 
needed to do more. 
Our inspections of infection prevention and control procedures in place in hospitals 
in 2019 focused on efforts to address the threat posed by the emergent multidrug 
resistant organism Carbapenemase Producing Enterobacteriacea (CPE), following 
the declaration of a national public health emergency by the Minister for Health. 
We found that hospitals had, in most cases, implemented or were close to fully
implementing the required measures needed to control rates of colonisation and 
infection related to this multidrug resistant organism. This was an improvement 
on 2018, where HIQA continually needed to raise concerns with hospitals around 
these measures. We also looked at measures to ensure effective decontamination of
reusable invasive medical devices, and found generally positive results in hospitals 
related to practices identified. 
In 2019, we completed a monitoring programme against the National Standards for
Safer Better Maternity Services, with a focus on obstetric emergencies. Between 2018 
and 2019, we inspected all 19 maternity units and hospitals in Ireland to ensure 
that they had the required measures in place to detect and respond to potentially
life threatening emergencies for women or babies using maternity services. Overall, 
findings from this inspection programme were generally positive, with most hospitals 
demonstrating high levels of compliance against the majority of the national 
standards assessed. However, we identified a number of specific areas that required 
improvement at individual hospital level and nationally through this programme, and 
made recommendations for local and national action in an overview report published 
in early 2020. 
In 2019, we also commenced a new programme of monitoring against the National 
Standards for Safer Better Healthcare in rehabilitation and community inpatient 
healthcare services during 2019. This monitoring programme has placed particular
focus on ensuring these services are compliant with national standards to ensure 
patient safety, including medicines safety and infection prevention and control. 
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This was the first time that HIQA had commenced inspection of these healthcare 
services. During the year, we carried out inspections in six rehabilitation and 
community inpatient healthcare services. This programme of inspection has allowed 
these facilities to become familiar with HIQA standards. This will be important going 
forward as these services, alongside their peers in acute hospitals, will fall under the 
monitoring and ultimately licensing regimes envisaged through planned legislation 
such as the Patient Safety (Notifiable Patient Safety Incidents) and Patient Safety
(Licensing) Bills. 
National Care Experience Programme 
The National Care Experience Programme is a joint initiative by HIQA, the HSE 
and the Department of Health. It seeks to improve the quality of health and social 
care services in Ireland by asking people about their experiences of care and acting 
on their feedback. We do this by conducting the National Inpatient Experience 
Survey and the National Maternity Experience Survey. Over the next few years, 
the programme will expand to include three further surveys of health or social care 
services: the care of women who have been bereaved by stillbirth and neonatal 
death; older person’s care and end-of-life care. 
Visit www.yourexperience.ie to find out more. 
The National Inpatient Experience Survey 
During the month of May 2019, 26,897 people from 40 acute hospitals were 
invited to participate in the third National Inpatient Experience Survey. In total, 
12,343 people took part in this survey, resulting in a response rate of 46%, 
compared to the 50% response rate achieved in 2018. The strong response rate 
indicates that patients in Ireland have a desire to talk about their experiences in 
hospital and to use their voice to improve our health service. In November 2019, 
we launched the full results of the survey and published a national overview report 
and 39 hospital reports. 
During 2019, we issued an academic call for research to be undertaken on the 
40,000 qualitative responses received to the 2017 and 2018 National Inpatient 
Experience Survey. Insight Centre for Data Analytics at National University of Ireland 
Galway (NUIG) were successful applicants to this, and are using machine learning to 
analyse the anonymised responses for key trends. The results of this analysis will be 
available on www.yourexperience.ie in 2020. 
20 To ensure an adequate sample size, women who give birth in smaller Irish hospitals or had a homebirth in November
2019 were also eligible to participate in the survey. 
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The National Maternity Experience Survey 
Women aged 16 or over who gave birth in October (or November20) 2019 were 
eligible to participate in the first ever National Maternity Experience Survey. The 
survey asks new mothers about their recent experiences of Ireland’s maternity
services — from antenatal care, through labour and birth, to postnatal care. The 
survey results will be published in September 2020 on www.yourexperience.ie.  
Survey hub 
We are currently developing a National Care Experience Programme hub that will 
provide support, guidance, information and leadership on the appropriate collection 
and use of care experience data for all engagement programmes in health and social 
care services. 
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4.3 Better Decisions
Providing advice, evidence and information to 
inform decisions 
As set out in our Corporate Plan, HIQA provides advice, evidence and information 
to inform decision-making in health and social care services. We do this by
conducting health technology assessments and by synthesising evidence to inform 
National Clinical Guidelines and national health policies through our HRB-CICER 
and Evidence Through Policy functions. We also make recommendations and set 
standards on the use of health information and the data that services collect. This 
section outlines the advice, evidence and information that we provided across these 
areas in 2019 to inform better decisions in the health and social care sector. 
Health technology assessment 
Under the Health Act 2007, HIQA has a statutory role to evaluate the clinical and 
cost-effectiveness of health technologies and to provide advice to the Minister
for Health and the HSE in this regard. This is called health technology assessment 
(HTA), and it informs investment decisions in health and social care. We also develop 
national guidelines to inform the production of timely, consistent and reliable 
assessments that are relevant to the needs of the people using health and social 
care services. 
HTA of C-reactive protein point-of-care testing 
We published a HTA on C-reactive protein (CRP) point-of-care-testing (POCT) 
to guide antimicrobial prescribing in primary care in Ireland on 23 May 2019. 
The HTA was submitted as advice to the Minister for Health, the Department of
Health, and the Health Service Executive (HSE) to inform decision-making on the 
implementation of a CRP POCT programme in primary care settings in Ireland. 
Following a request from the Department of Health, HIQA undertook the HTA
to establish the clinical and economic impact of providing CRP POCT in primary
care to inform prescribing of antibiotics for patients presenting with symptoms 
of acute respiratory tract infections. CRP POCT devices can be used to guide 
prescribing decisions by providing rapid (that is to say, during consultation) 
diagnostic information on the presence of viral versus bacterial infection. The device 
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is designed to support decision-making by identifying those patients who are most 
likely to benefit from an antibiotic and those who are not. 
The HTA evaluated the clinical effectiveness, diagnostic test accuracy, analytical 
performance, cost-effectiveness, and budget impact of implementing a CRP POCT
programme to guide antimicrobial prescribing in the community for acute respiratory
tract infections in Ireland. The report and recommendations were published 
following engagement with an expert advisory group and a five-week public and 
targeted consultation. 
The HTA advised that, given the uncertainty regarding the long-term sustainability
and effectiveness of CRP POCT, a carefully-managed and monitored pilot 
programme or partial rollout may offer the best prospect to evaluate a CRP POCT
programme and establish whether a national rollout of the technology is advisable. 
HTA of a PrEP programme 
Following a formal request from the HSE’s Clinical Lead in Sexual Health and 
endorsement of the request by the Department of Health, HIQA’s HTA of a pre-
exposure prophylaxis (PrEP) programme for populations at substantial risk of sexual 
acquisition of HIV was published on 14 June 2019. The HTA was finalised following 
a public and targeted consultation period, and was submitted as advice to the 
Minister for Health, the Department of Health and the HSE. 
Our HTA found PrEP to be safe and highly effective at preventing sexual acquisition 
of HIV infection in gay, bisexual and other men who have sex with men and in HIV-
negative partners of serodifferent couples (where one partner is HIV-negative and 
the other is HIV-positive and not on effective antiretroviral therapy). Additionally, 
an economic model was developed to estimate the costs and consequences of
providing a PrEP programme to individuals at substantial risk of infection. PrEP was 
found to be more effective and less costly than not providing PrEP. 
Therefore, we advised the Minister for Health that the successful implementation of
a national PrEP programme in Ireland would be safe, effective and cost-saving. Since 
the publication of the HTA, PrEP has been made available free-of-charge for eligible 
individuals enrolled in the PrEP programme. 
HTA of TAVI in patients with severe symptomatic aortic stenosis 
We published a HTA of transcatheter aortic valve implantation (TAVI) in patients 
with severe symptomatic aortic stenosis at low or intermediate risk of surgical 
complications on 5 December 2019. The HTA was submitted as advice to the 
Minister for Health, the Department of Health and the HSE to inform decision-
making on the use of TAVI in these patients. 
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The HTA was requested by the HSE. Currently, TAVI is primarily offered as an 
alternative to surgical aortic valve replacement (SAVR) in patients that are otherwise 
inoperable or at high risk of surgical complications. We evaluated the clinical 
effectiveness, cost-effectiveness, and budget impact of extending TAVI to patients at 
lower levels of surgical risk in the Irish public healthcare system. The final report and 
recommendations were informed by a review of epidemiology, a systematic review
of the clinical effectiveness and safety of TAVI compared with SAVR, an economic 
evaluation, an ethical and organisational analysis, and intensive engagement with an 
expert advisory group. 
The HTA advised that TAVI should be made available to patients aged 70 years and 
over with severe symptomatic aortic stenosis at low or intermediate surgical risk in 
the Irish public healthcare system. 
Systematic review of newer and enhanced influenza vaccines 
On 12 September 2019, HIQA was awarded a contract to commence work on 
the efficacy, effectiveness and safety of newer and enhanced seasonal influenza 
vaccines for the prevention of laboratory-confirmed influenza in adults. The review
was commissioned by the European Centre for Disease Prevention and Control 
(ECDC), an agency of the European Union, and involves close collaboration with the 
EU/EEA National Immunisation Technical Advisory Groups. 
Seasonal influenza A and B viruses circulate and cause disease in humans every year
and in temperate climates winter epidemics occur yearly. Most groups for whom the 
seasonal influenza vaccine is recommended may annually receive either a trivalent 
or quadrivalent inactivated seasonal influenza vaccine, although new and enhanced 
seasonal influenza vaccines are starting to be used in some national seasonal 
influenza immunisation programmes targeting mainly vulnerable groups, such as 
the elderly. There is a need to monitor performance of the newer and enhanced 
seasonal influenza vaccines compared to the standard seasonal influenza vaccines, 
to drive public health decision-making and advance new vaccination strategies. 
The systematic review will conclude in early 2020 and will be submitted to a peer-
reviewed journal for publication. 
HTA of birth cohort testing for hepatitis C 
In 2019, HIQA commenced work on a HTA of offering testing for the hepatitis 
C virus (HCV) to people in Ireland born between 1965 and 1985. The HTA was 
prioritised following publication of an Irish National Clinical Guideline for Hepatitis C 
Screening, quality assured by the National Clinical Effectiveness Committee, which 
included a conditional recommendation to offer one-off testing to people born 
between 1965 and 1985 (that is, birth cohort testing) subject to the outcome of a 
full HTA. 
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Birth cohort testing involves offering one-time testing for HCV to people born 
during a particular period of time. The birth cohort to be tested was identified based 
on national data, which indicated that the prevalence of hepatitis C infection in 
Ireland is highest amongst those born between 1965 and 1985 (72.5% of cases). 
Compared with risk-based testing, this type of testing avoids the need to identify
specific behavioural risks as the basis for testing. Individuals identified as having 
chronic hepatitis C infection would be offered curative treatment thereby avoiding 
progression to ill health and associated healthcare costs. 
The aim of the HTA is to establish the clinical and cost-effectiveness of birth 
cohort testing for hepatitis C in Ireland. In addition, the assessment will estimate 
the budget impact of introducing a birth cohort testing programme and assess the 
organisational and resource implications of such a service. An expert advisory group 
comprising representatives from key stakeholder groups has been convened and 
will advise us during the course of the HTA. The HTA is scheduled to be finalised 
in 2020 following public and targeted consultation and will be provided as advice 
to the Minister for Health to inform a decision on whether or not to provide birth 
cohort testing for hepatitis C in Ireland. 
National HTA guidelines 
Since 2010, HIQA has developed and published a suite of national HTA guidelines 
to support the production of evaluations that are timely, reliable, consistent and 
relevant to the needs of decision-makers and key stakeholders. With the support of
the HTA Scientific Advisory Group (which includes broad representation from key
stakeholders in healthcare in Ireland), this suite of guidelines is regularly updated 
and expanded to meet the needs of HTA activity in Ireland. During 2019, we 
updated two guidelines with the support of the HTA Scientific Advisory Group and 
substantial input from the National Centre for Pharmacoeconomics. 
We updated our Guidelines for Evaluating the Clinical Effectiveness of Health 
Technologies in Ireland in 2019. A new appendix was added with an illustrative 
example of a network meta-analysis. 
The Guidelines for the Economic Evaluation of Health Technologies in Ireland were also 
updated in 2019 to include the new test discount rate. 
HRB-CICER – Clinical guideline support 
In 2016, HIQA was awarded a contract for €2.25 million by the Health Research 
Board (HRB) to establish the HRB Collaboration in Ireland for Clinical Effectiveness 
Reviews (HRB-CICER). HIQA’s main collaborator is the HRB Centre for Primary Care 
Research (HRB-CPCR) in the Royal College of Surgeons in Ireland (RCSI). 
59 











HRB-CICER aims to deliver a high-quality evidence base with regard to systematic 
review of clinical-effectiveness, systematic review of cost-effectiveness and budget 
impact analysis to support guideline developers in developing evidence-based 
recommendations included in national clinical guidelines and national clinical audits. 
These guidelines and audits are quality assured by the National Clinical Effectiveness 
Committee (NCEC) and mandated by the Minister for Health for implementation 
by the HSE. The collaboration also provides training in evidence synthesis and 
advises the NCEC on improvements in methodological developments in evidence 
generation, and on research gaps with regard to the evidence base and how they
may be best addressed. 
HIQA also provides support to the NCEC through membership of the Committee 
and by assisting with the prioritisation and appraisal of submitted guidelines. In 
2019, HIQA provided expert input to NCEC appraisal and prioritisation teams for
the following guidelines: 
■ Appropriate prescribing of psychotropic medication in people with dementia 
■ Nutrition screening and use of oral nutrition support for adults in the acute 
care setting 
■ Diagnosis and Staging of Ovarian Cancer. 
National Clinical Guideline on Diagnosis and Staging of Ovarian Cancer 
HRB-CICER supported the development of a National Clinical Guideline for the 
Diagnosis and Staging of Ovarian Cancer by undertaking a systematic review of
economic literature, developing a preliminary cost analysis of the implementation 
of the guideline and by providing training to the research team from the National 
Cancer Control Programme on conducting systematic reviews of economic literature. 
The guideline was launched by the Minister for Health in August 2019. 
Guideline development 
We also provided the following to guideline development groups in 2019: 
■ a systematic review of three clinical effectiveness questions and one review of
qualitative literature to support the development of the care of the dying adult 
in the last days of life guideline 
■ a systematic review of economic literature to support the stratification of
clinical risk in pregnancy guideline 
■ a systematic literature review of seven economic questions to support the 
development of the chronic obstructive pulmonary disease in adults guideline 
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■ a systematic review of clinical and economic literature on interventions to 
improve hand hygiene adherence to support the healthcare-acquired infection 
guideline 
■ a systematic review of the prevalence of intraoperative massive haemorrhage, 
and a systematic review of relevant clinical guidelines to support the 
development of the intraoperative massive haemorrhage guideline 
■ a systematic review of qualitative literature to support the update to the 
national early warning system guideline 
■ a budget impact analysis of the implementation of the stratification of clinical 
risk in pregnancy guideline 
■ a systematic review of clinical and economic literature on nutritional screening 
to support the guideline on nutrition screening and use of oral nutrition 
support for adults in the acute care setting. 
In 2019, work began on: 
■ a budget impact analysis of the implementation of the updated national early
warning system guideline 
■ a systematic review of clinical and economic literature on single patient room 
accommodation compared to multi-bed rooms in acute settings to support the 
development of healthcare-acquired infection guideline. 
During 2019, we also provided training to 60 individuals involved in research in 
Ireland. A training session on the methodology for guidelines was provided at the 
National Patient Safety Office Conference. An introduction to budget impact analysis 
of National Clinical Guidelines was also provided. Two full days of training on the 
use of GRADE (Grading of Recommendations Assessment, Development and 
Evaluation) was provided in January and March to multiple guideline development 
group members. 
Health Research Board Emerging Investigator Award 
HIQA is a co-applicant on the Health Research Board Emerging Investigator Award 
(EIA) led by Dr Barbara Clyne, HRB-CICER and Royal College of Surgeons in Ireland, 
entitled Evidence synthesis and translation of findings for national clinical guideline 
development: addressing the needs and preferences of guideline development groups. 
This research aims to support clinical guideline development processes underlying 
the work conducted by HRB-CICER by developing a ‘toolkit’ for evidence producers 
and end-users. This toolkit will support: 
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1. Optimal selection of evidence synthesis methods 
2. Communication of the findings of evidence synthesis and 
3. Translation of research evidence into recommendations. 
Health Research Board Collaborative Doctoral Award 
HIQA is a co-applicant on the Health Research Board Collaborative Doctoral 
Award led by Professor Susan Smith, Royal College of Surgeons in Ireland, which 
funds a programme entitled Managing complex multimorbidity in primary care: a 
multidisciplinary doctoral training programme. The programme includes a collaboration 
with HIQA to evaluate the costs of adhering to clinical guidelines falling on patients 
with complex multimorbidity and their carers, an area under researched to date. 
HRB-CICER – Evidence for Policy
Our Evidence for Policy (EfP) Team was established in 2018 following a request 
from the National Patient Safety Office (NPSO) in the Department of Health. The 
EfP Team is responsible for the effective implementation of evidence synthesis 
programmes to deliver high-quality research to support the development of policy
by the Department of Health and is funded through an extension of the grant 
agreement by the Health Research Board for HRB-CICER. 
Evidence review of specialist cardiac services 
The National Review of Specialist Cardiac Services is an independently chaired 
review of national clinical cardiac services in Ireland established by the Minister for
Health. The review will recommend the optimal configuration of a national adult 
specialist cardiac service in Ireland, aiming to achieve optimal patient outcomes at a 
population level with particular emphasis on the safety, quality and sustainability of
the services that patients receive. During 2019, we carried out an evidence review
to inform the National Review of Specialist Cardiac Services. 
The three main objectives of our evidence review were to: 
1. identify and describe existing models of specialist cardiac networks focused 
on the urgent treatment of patients presenting with major heart attacks. Major
heart attacks are caused by a blockage in the arteries supplying blood to 
the heart muscle. They are considered a medical emergency and are treated 
urgently by using either a clot-busting drug (thrombolysis) or by inserting a 
guide wire into the artery and opening the vessel using a balloon to allow
the blood to flow to the heart muscle again. This is known as a primary
percutaneous coronary intervention (PCI), and is done in a hospital that has an 
emergency catheterisation laboratory (cath lab). 
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2. identify international best practice for centres providing PCI to treat major
heart attacks and to examine the evidence underpinning these criteria. 
3. identify evidence on the safety and effectiveness of strategies for managing 
major heart attacks including primary PCI and thrombolysis approaches in 
centres without PCI-capability. 
The National Review will be launched by the Department of Health in 2020. 
The economic burden of antimicrobial resistance in the public acute care system in 
Ireland 
Antimicrobial resistance (AMR) is defined as the ability of a micro-organism to stop 
an antimicrobial from working against it. AMR is a global public health concern; as 
standard antimicrobial treatments become ineffective, infections persist and spread, 
increasing morbidity and mortality. Rising rates of AMR will make it increasingly
difficult and expensive to control and treat infections, and places a significant burden 
on society. 
In 2019, we began a study to estimate the economic burden of antimicrobial 
resistance (AMR) in the public acute care system in Ireland. This costing study is 
being undertaken in fulfilment of listed activities aligned with Strategic Objective 
5 of Ireland’s National Action Plan on Antimicrobial Resistance (2017-2020). 
Economic evidence of the current cost of AMR could inform investment decisions 
and promote, and provide a metric against which to measure, the use of proposed 
evidence-based, cost-effective solutions to challenges faced as a result of AMR. 
An Expert Advisory Group comprised of representative stakeholders is providing 
guidance and expert input to the project. The report will be provided as advice to 
the Minister for Health in 2020. 
Health information 
Health and social care are information-intensive, generating huge volumes of data 
every day. It is important that such information is managed in the most effective way
possible in order to ensure high-quality, safe health and social care. 
Health information is used to improve health and social care, to inform decision-
making, monitor diseases, organise services, inform policy-making, conduct high-
quality research and plan for future health and social care needs, both at national 
and local levels. High-quality health information is a fundamental requirement for
delivering health and social care and making healthcare planning decisions. 
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Although there are already a number of examples of good practice in Ireland, there 
are also major gaps, silos of information and duplication in the country’s health 
information landscape. Our work aims to address these challenges. 
Development of recommendations on a consent model for collection, use and sharing of
health and social care information in Ireland 
During 2019, we began to develop recommendations on a model for the collection, 
use and sharing of health and social care information in Ireland. 
We conducted a review to identify best practice internationally, completed a 
desktop review and contacted experts in several countries to gather the most up-
to-date information. Key themes emerging from the international review include: 
■ consent 
■ information governance 
■ public trust and engagement 
■ engaging healthcare professionals 
■ legislation 
■ preparing for new technologies. 
We continue to hold meaningful engagement with key stakeholders such as the 
Department of Health and the HSE in relation to this project. An advisory group 
of key stakeholders, such as patients, healthcare professionals and national health 
and social care data collections, was convened to support the development of the 
recommendations. The first Advisory Group meeting was held in November 2019. 
We will hold a public consultation on these recommendations in 2020. 
National standard on information requirements for national community-based 
ePrescribing 
Electronic prescribing can deliver significant benefits for patients, prescribers, 
pharmacists and others involved in the process. In particular, ePrescribing can 
improve patient safety, for example, by reducing errors of mistaken identity, 
incorrect dosage, incorrect medication and adverse drug interactions. It can also 
reduce the number of pharmacist interventions significantly. Moreover, ePrescribing 
costs less and takes less time than processing the same prescriptions manually. We 
published a National standard on information requirements for national community-
based ePrescribing, which defines the information requirements required to implement
community-based ePrescribing and dispensing in Ireland. It was approved by the
Minister for Health in April 2019. 
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Development of digital learning modules on improving data quality for health and 
social care 
High-quality data can be used to inform decision-making, identify deficiencies, 
prioritise initiatives, monitor diseases, organise services, support policy-making, 
conduct quality research, evaluate impact and plan for future health and social care 
needs, both at local and national level. 
During 2019, we published two digital learning modules to support HIQA’s Guidance 
on a data quality framework for health and social care. These modules highlight 
the importance of data and information quality for all health and social care 
professionals. 
The first module — entitled ‘Introduction to data quality’ — is aimed at all health and 
social care professionals. It is a 20 minute course that introduces the learner to the 
concept of data and information quality, and highlights the importance of collecting 
and using quality data and information as part of the process of providing safe and 
effective health and social care. The importance of data and information quality
is presented within this module from the perspective of a clinician and a patient 
advocate. 
The second module — entitled ‘Developing a data quality framework within health 
and social care’ — is a more detailed learning tool aimed at all health and social care 
organisations whose remit involves the collection, processing, use or interpretation 
of data or information, and whose responsibility it is to ensure the quality of that 
data or information. This module details the steps that organisations can take to 
develop a data quality framework to support them in assessing and improving the 
quality of their data and information. The National Office of Clinical Audit (NOCA) 
and the Hospital In-Patient Enquiry (HIPE) team within the Healthcare Pricing Office 
(HPO) share their experience of implementing HIQA’s data quality framework in this 
module. 
eHealth – patient summary records 
HIQA has undertaken a programme of work to plan and prepare for the introduction 
of a national electronic patient summary in Ireland. This includes the National 
Standard on information requirements for a national electronic patient summary, which 
was published in January 2019 and approved by the Minister in April 2019. This 
National Standard defines the information requirements for an electronic patient 
summary for the purpose of unscheduled care, for example, out-of-hours and 
emergency care. The Sláintecare implementation plan prioritises the design and 
rollout of a range of primary and community-based information communication 
technology services, including summary care records.  
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Following the launch of the National Standard, we began to develop 
recommendations on the implementation of a national electronic patient summary
in Ireland. We presented findings from an international best practice review of
implementing electronic patient summaries to a specially convened Advisory Group 
in July. 
Following feedback from the first meeting of the Advisory Group, the scope of the 
recommendations was expanded to include: 
■ an ‘as is’ review of the Irish eHealth landscape 
■ and a set of materials for learning including educational materials for key terms. 
The project will continue into 2020. 
Furthermore, we are currently carrying out a best practice review of developments 
and trends in eHealth. We looked at initiatives undertaken by the World Health 
Organization, European Union and initiatives which have been undertaken in 
countries such as Denmark Scotland, England, France, Estonia and New Zealand. 
Finding from the review will inform our future work. 
National data collections review programme 
HIQA is currently undertaking a structured review programme to assess compliance 
with information management standards for national data collections in Ireland. 
The aim of this programme is to improve information management practices by
assessing compliance with the standards in individual national data collections. 
Ultimately, the review programme was developed to drive improvements by
identifying areas of good practice and areas where improvements are necessary
across national data collections. 
In 2019, we published information management reviews of: 
■ the HSE Primary Care Reimbursement Service (PCRS) 
■ and the HSE Computerised Infectious Disease Reporting (CIDR) system. 
PCRS 
The PCRS is responsible for reimbursing healthcare professionals for the free or
reduced cost services they provide to the public under various national health 
schemes, including the General Medical Services (GMS) Scheme. Additionally, 
through its eligibility function, the PCRS processes all medical and GP visit card 
applications. The PCRS is an extremely valuable national data collection. For
example, the PCRS holds the most comprehensive repository of national prescription 
data and the largest data source for measuring drug exposure in specific populations 
in Ireland. 
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We made eight recommendations to improve information management practices 
in PCRS. Our review identified a number of areas of good practice in relation to 
information management. However, key areas for improvement were also identified 
in relation to the need for a more strategic focus on information management across 
the entire organisation and, in particular, better use and dissemination of the rich 
data and information that the PCRS holds. This review also found that while there 
are clear governance arrangements in place at an operational level in relation to 
information management within the PCRS, there is a less structured approach in 
place in terms of how information management is strategically discussed, planned 
and managed across the organisation. Specific roles and responsibilities around 
aspects of information management lacked clarity, including the implementation of
audit recommendations or how data generated by the PCRS is used effectively to 
improve the service. 
CIDR
CIDR is Ireland’s national system for surveillance of notifiable infectious diseases. 
There are 260 CIDR users in clinical laboratories, departments of public health and 
the Health Protection Surveillance Centre (HPSC) who rely on CIDR to notify cases 
of 78 different infectious diseases. Public health departments use CIDR to monitor
individual cases of infectious disease and to record data including the associated 
pathogen, the clinical symptoms, treatment and outcome. They also monitor for
outbreaks or unusual clusters of disease in order to be able to take appropriate 
measures to prevent further spread of the disease. The HPSC, as the managing 
organisation for the CIDR system, monitor the national incidence of infectious 
disease and advise the health service, the government and the public on the 
appropriate measures to take to protect against emerging threats. 
HIQA’s review highlighted good practice in relation to information security and 
information governance. However, we made eight recommendations to improve 
data collection, including the need for the current governance arrangements to 
be enhanced and the requirement for an overarching strategy for information 
management across the public health service. The timing of this review of CIDR was 
particularly opportune as it coincided with the plans for a major restructuring of
public health services in Ireland. 
eHealth services review programme 
In 2019, HIQA commenced a review programme to assess national eHealth services 
against national standards. 
The programme will assess compliance of eHealth services within the HSE against 
the National Standards for Safer Better Services. The review programme aims to 
67 










drive quality improvements by identifying areas of good practice and areas where 
improvements are necessary across eHealth services, ultimately contributing to the 
delivery of safe and reliable patient care. 
A significant amount of patient information is shared electronically in Ireland using 
such eHealth services—including electronic referrals, electronic transmission of
laboratory results and radiology reports and electronic discharge summaries. 
An eHealth service is defined as the technology, people and processes which 
facilitate the sharing of electronic patient information between health and social 
care services across organisations and or care settings. The review programme is 
assessing compliance with the national standards under the themes of person-
centred care, leadership, governance and management, use of information, 
information governance and workforce. 
To date, we have developed a robust methodology to enable HIQA to conduct 
reviews. The methodology includes a framework that promotes consistent evidence-
based assessment and judgment through the use of standardised processes. HIQA
has completed a privacy impact assessment, and also developed a prioritisation 
process of eHealth services. HIQA plans to engage with and assist service providers 
to drive improvements in this area and a guidance document which outlines the 
main stages involved in a review is available on www.hiqa.ie 
The National Electronic Referrals Service was prioritised for the first review as over
30% of all general practitioner (GP) referrals to hospital outpatient departments are 
sent electronically. The review will be published in 2020. 
Regulation Handbook 
In 2019, we published a Regulation Handbook for registered providers and staff
working in designated centres. The handbook provides an overview of how we 
regulate to safeguard vulnerable people living in residential care. It explains the 
legislation behind our regulatory powers and outlines our registration, inspection 
and enforcement processes. It also helps providers of designated centres to better
understand their role and responsibility. The handbook has been sent to every
designated centre across the country, and we hope it empowers providers to 
safeguard vulnerable people using services and improve all aspects of their quality
of life. 
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In 2019, HIQA was successfully awarded €250,000 in funding from the Health 
Research Board under the Secondary Data Analysis Project Grant. 
In collaboration with the Dutch Health & Youth Care Inspectorate, we applied to 
undertake an indepth analysis of statutory notifications received from social care 
services in Ireland. 
HIQA receives over 15,000 notifications from social care services annually, providing 
a rich source of data about the quality and safety of these services. Commencing in 
2020, this research will help us make better decisions on regulated services by: 
■ providing an overview of notifications at a national level 
■ identifying targets for quality and safety improvement initiatives 
■ facilitating wider use and analyses of notification data 
■ sharing good practice when dealing with adverse events 
■ creating reporting and risk-rating notification efficiencies 
■ informing notification prioritisation in practice and policy 
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      4.4 Independent Assessment
Providing a reliable source of information to the public 
HIQA is committed to providing a reliable source of information to the public. We 
publish all our findings, reports and recommendations in a timely way. We also aim 
to build on public trust by engaging with people with experience of using health 
and social care services, the general public, and the staff who work in or manage 
services. We do this through holding public consultations and focus groups, forming 
advisory groups, and meeting people with experience of care. This is essential to 
informing our work. Public input and feedback is essential in ensuring that our work 
is informed by first hand experience of working in and accessing services, as well as 
the best available national and international evidence and literature. 
We also attend conferences and events to share our work with interested partner
bodies and stakeholders, and take part in consultations run by other bodies. 
Public consultations 
To inform the development of our work in 2019, we held the following four public 
consultations: 
■ Scoping Consultation to inform the development of Draft National Standards 
for Children’s Social Services 
■ Draft Guidance on a Human Rights-Based Approach to Care and Support in 
Health and Social Care Settings 
■ Draft HTA of a PrEP programme 
■ Draft HTA of C-reactive protein point-of-care testing to guide antibiotic 
prescribing. 
We invited the public, people with experience of using services, their families, staff
who work in services, advocates, researchers and policy-makers to give us feedback 
on our work in these areas. From the four consultations held in 2019, we received 
responses from 202 individuals or groups. 
Engagement with residents in social care services 
A key aspect of every inspection is inspectors meeting and spending time with 
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residents, while respecting everyone’s individual preferences, rights and needs. 
Over the course of 2019, we met with a large number of residents who live in 
designated centres, and children who access social services throughout Ireland. Our
inspectors spent time listening to and observing life for residents and children. 
The majority of residents and children told inspectors that they were happy in their
home and that they felt safe. 
Services for people with disabilities 
In designated centres for people with disabilities, residents told us that they knew
how to raise a complaint or concern, and they felt they could easily speak to any
member of staff if necessary. However, some residents expressed concerns about 
the follow up to complaints they had made. 
Most residents told inspectors that they felt they had choice and control over their
daily activities and were supported by staff according to their needs and wishes. 
However, inspectors found that residents living in congregated settings did not have 
the same choice as people living in the community and often their day primarily
focused on campus-based activities. In many cases, these activities were further
limited by a lack of staff available to support residents. 
Residents enjoyed telling and showing inspectors how they liked to spend their
time and of the activities or persons that were particularly important to them. They
often told inspectors about the support they received from staff, how they liked 
the staff who worked with them and were familiar to them. Residents spoke about 
being comfortable speaking to staff about anything that was effecting them. Some 
residents thought that things could be better if there was more staff in the centres. 
Many residents living in the community said that they had developed independent 
living skills or were being supported to engage in tasks such as cooking, cleaning 
and laundry tasks. This is in contrast to those living in congregated settings, where 
inspectors found that many residents were not involved or supported to participate 
in their daily living routines. 
Residents in a number of congregated settings expressed their concern about the 
delay to transition to community-based services. Some residents told inspectors that 
they had stopped engaging in advocacy meetings as progress was not being made. 
We also recognise the importance of meeting with people with disabilities outside of
the inspection process to listen to their views about the work of inspectors. 
In 2019, inspectors were invited to attend 18 resident meetings across the 
country. Inspectors attended the meetings as guests and were welcomed by their
hosts. Inspectors listened to what residents had to say about their experiences of
inspections. Residents also told inspectors abouts aspects of their service which 
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were most important to them and what they believed inspectors should be looking 
at when they visit centres. 
We have reviewed the information that residents gave us and will send a summary
of the information provided back to each resident group. We have also committed 
to developing our own plan based on what residents told us to inform the way that 
inspectors carry out their inspection activity. 
Given the success of the engagement in 2019, and following requests from other
resident groups, we intend to repeat this programme again in 2020. 
Nursing homes 
In 2019, we held five regional sessions, offering nursing home residents, their
relatives and friends, and the general public, the chance to meet the inspectors 
responsible for the inspection of nursing homes and to talk about their experiences 
of nursing home care. Over 100 residents and relatives attended these sessions, 
providing us with valuable insights into their lives and what is important to them. 
Children 
In 2019, we worked closely with Hub na nÓg, within the Department of Children 
and Youth Affairs, to develop a training programme utilising the Lundy Model for
inspectors on the voice of the child – focusing on Article 12 of the United Nations 
Convention on the Rights of the Child (UNCRC). 
Inspectors subsequently utilised the Lundy Model of Participation and the tools and 
participative methodologies during inspections to capture the voice of the children 
that they meet with during foster care, children’s residential centres, and Oberstown 
Children Detention Campus inspections. 
Engagement with health and social care professionals 
Nursing homes 
We held a series of regional meetings with registered providers of nursing homes 
during 2019. 
Over 500 providers and persons in charge of nursing homes attended five regional 
sessions. These sessions provided an opportunity for us to share information on the 
thematic inspections and for staff from nine nursing homes to present examples of
good practice in the delivery of nursing home care. 
Other stakeholders that we engaged with during 2019 included: 
■ Sage 
■ Nursing Homes Ireland                                                        
73 












■ Irish Congress of General Practitioners                                                         
■ Irish Guide Dogs for the Blind Association                                          
■ National Treatment Purchase Fund.  
Disability services 
We held four roadshows, attended by over 500 providers and managers from 
centres for people with disabilities in 2019. At these events, we spoke about how
regulation can be used to improve the rights and dignity of residents living in 
designated centres, and how good governance arrangements leads to improvements 
in the rights and choices for residents. 
In addition, we held three provider representative forum meetings during 2019 with 
representation at these meetings including the National Federation of Voluntary
Bodies, the Disability Federation of Ireland, Not for Profit Business Association and 
the HSE in their capacity as a direct service provider. This meeting has provided a 
valuable opportunity for the exchange of information between the regulator and the 
national provider representatives. 
Healthcare 
During 2019, HIQA completed an extensive programme of stakeholder engagement 
to support commencement of regulation in ionising radiation. These key stakeholders 
included the Department of Health, the HSE, private hospitals and the Irish Dental 
Association.  
We also held eight engagement sessions for 450 undertakings throughout the 
country in June 2019. We maintained regular liaison and collaborative working 
with the Environmental Protection Agency (EPA), who regulate non-patient ionising 
radiation exposures. 
During 2019, HIQA also undertook a number of specific stakeholder engagement 
exercises to help to both support the development of our work and assist providers 
in meeting the national standards. These exercises included: 
■ ongoing engagement with HIQA’s maternity services advisory group to support 
this programme of monitoring. 
■ external engagement with key national bodies to conclude the maternity
services review, including the HSE National Women and Infants Programme, 
Senior HSE management, and the Director General of the HSE. 
■ continued attendance in observance at the RCSI/RCPI Healthcare Associated 
Infection and Antimicrobial Resistance Clinical Advisory Group. 
■ two stakeholder engagement sessions with providers of rehabilitation and 
community inpatient healthcare services (one in Cork and one in Dublin). 
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On 13 February 2019, HIQA addressed the Joint Committee on Children and 
Youth Affairs in relation to recruitment and retention of Tusla staff. In its opening 
statement, HIQA reiterated findings of multiple inspection reports, including the 
findings of its investigation into Tusla’s management of child sexual abuse referrals 
against adults of concern that Tusla had been unable to recruit a sufficient number
of social workers with the right skill-mix to carry out its work programme. 
While HIQA acknowledged that Tusla was indeed experiencing a shortage of
qualified social workers, the 2018 investigation identified that there was no 
comprehensive, strategic approach to workforce planning in place, informed by the 
reality of the current employment market, and there was little evidence to show that 
a review of current processes and requirements, and or consideration of upskilling 
other social care disciplines had happened or was formally underway. 
We highlighted the need for Tusla to take a strategic approach to workforce 
planning, as it could not continue to rely on recurring staff shortages as the default 
reason for failing to deliver efficient and safe services to children and families. 
Health technology assessment
National and international networks 
In 2019, we signed a memorandum of understanding (MoU) between national health 
technology assessment (HTA) bodies in Scotland, Wales and Ireland. 
The MoU established a collaborative approach to the identification and assessment 
of new health technologies between HIQA, the HSE, Health Technology Wales and 
the Scottish Health Technology Group. 
HIQA is a member of both Health Technology Assessment international (HTAi) and 
the International Network of Agencies for Health Technology Assessment (INAHTA). 
These international collaborations allow us to share research and to collaborate on 
and co-produce evidence reviews on health technologies. 
HIQA has been nominated by the Department of Health to represent Ireland in 
the European Network for Health Technology Assessment (EUnetHTA) since 2008. 
EUnetHTA is a collaboration of over 80 HTA organisations from all 28 EU member
states, Norway and Switzerland. It aims to bring about effective and sustainable HTA
collaboration that creates added value at European, national and regional levels. 
A series of Joint Actions have been undertaken to foster interagency cooperation, 
improve HTA output and avoid duplication of effort. This work has also informed the 
establishment of a permanent Europe-wide network of HTA agencies. 
HIQA is an active participant in four of the work packages included in EUnetHTA’s 
third Joint Action 2016-2021. HIQA’s Director of HTA and Deputy Chief Executive, 
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Dr Máirín Ryan is an elected member of the EUnetHTA Executive Board. 
During 2019, we worked with EUnetHTA on a number of projects, including: 
■ activity centre lead and lead author on a rapid relative effectiveness 
assessment (REA) of C-reactive protein point-of-care testing to guide antibiotic 
prescribing for respiratory tract infections in primary care settings. 
■ a EUnetHTA taskforce workshop on HTA and Medical Devices. 
■ text and review support for the guidance document ‘Practical considerations 
when critically assessing economic evaluations’.
■ lead author on an update of methodological guideline Comparators & 
Comparisons: Direct and indirect comparisons. 
■ lead author on a standardised operating procedure for data analysis [in the 
context of relative effectiveness assessment]. 
We also contribute to a number of advisory groups and networks run by external 
stakeholders. These include the Technology Review Group of the National Cancer
Control Programme, the Rare Diseases Technology Review Committee, the HSE 
HTA Expert Group, the SPHeRE Steering Group, HSE Community Health Schemes 
(Medicines) Open Data Project Governance Committee, the Department of Health 
Implementation Oversight Group for the development of a new model for the 
delivery of public health medicine in Ireland and the Medicinal Cannabis Expert 
Reference Group. 
Evidence Synthesis Ireland 
The HTA Directorate collaborates on the Evidence Synthesis Ireland initiative led 
by Professor Declan Devane, NUIG, which aims to strengthen Ireland’s capabilities 
in evidence synthesis to promote evidence-informed health decision-making. 
Evidence Synthesis Ireland is funded by the HRB and the Public Health Agency, 
Northern Ireland. HIQA is one of its four placement sites for successful applicants to 
undertake training in systematic review and other evidence synthesis skills. In 2019, 
an ESI fellow worked with the HRB-CICER team on a systematic review to inform 
the care of the dying adult in the last days of life guideline. 
The Director of HTA is a member of the International Advisory Board for Evidence 
Synthesis Ireland. 
IPPOSI programme 
HIQA provided support for the 2019 IPPOSI Patient Education Programme. The 
health technology assessment module of the programme is jointly delivered by
members of the National Centre for Pharmacoeconomics and HIQA. The programme 
is attended by patients and patient advocates and is designed to enable and 
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empower them to work effectively with Irish and EU-level agencies and authorities. 
National Inpatient Experience Survey Conference 
We held the first National Inpatient Experience Survey Conference in March 2019. 
The theme of the conference, “Knowing what matters to you and doing something 
about it”, focused on quality improvement initiatives being implemented in hospitals 
around the country. 
The conference highlighted the findings from the 2017 and 2018 surveys and 
showcased how healthcare professionals, stakeholders and patients can work 
together to improve experiences for all in our hospitals. The conference was 
attended by over 300 health professionals. 
Conferences 
During 2019, our staff attended a number of national and international conferences 
to present on HIQA’s research and work. These events allowed us to share our
research, learnings and findings with other health researchers, health professionals 
and service users. Examples include: 
■ The future of safe prescribing; a conference of the British Pharmacological 
Society and Royal College of Physicians in Ireland. 
■ 2019 National Health Outcomes Conference, Dublin. 
■ 2019 ISPOR Student Chapter, Dublin. 
■ 2019 Irish Postgraduate and Early Career Economists Conference, Galway. 
■ 2019 Health Technology Assessment International Annual Meeting, Cologne. 
■ 2019 SPHeRE Peer Learning Event, Trinity College Dublin. 
■ 2019 National Patient Safety Office 4th Annual Conference, Dublin. 
■ 2019 ISPOR 22nd Annual European Congress, Copenhagen. 
■ 2019 Guidelines International Network (GIN) Annual Meeting, Adelaide. 
■ 2019 Health Informatics Society of Ireland Conference, Dublin. 
■ 2019 National Patient Safety Office Conference, Dublin. 
■ 2019 National Conference for Immunisation Administrators, Dublin. 
■ 2019 Council of Clinical Information Officers (CCIO) annual conference, 
Ireland. 
■ 2019 The International Society for Quality in Health Care (ISQUA), South 
Africa. 
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For the year ended 31 December 2019 
This report addresses the requirements in the Code of Practice for the 
Governance of State Bodies (2016) set out in the Business and Financial Reporting 
Requirements, Section 1.9 which outlines the items for inclusion in the Chairperson’s 
Comprehensive Report to the Minister for Health. 
■ A statement on internal control is included in this report. 
■ I confirm that there were no commercially significant developments affecting 
HIQA during the year, including the establishment of subsidiaries or joint 
ventures and share acquisitions. 
■ There are no undisclosed off-balance sheet financial transactions. 
■ I affirm that all appropriate procedures for financial reporting, internal audit, 
procurement, travel and asset disposals are in place. 
■ I affirm that Codes of Business Conduct for Directors and Employees have 
been put in place and are adhered to. 
■ I affirm that Government policy on the pay of the Chief Executive and all other
HIQA employees is being complied with. 
■ I affirm that Government guidelines on the payment of Directors’ fees, as 
conveyed by the Department of Health, are being complied with. A schedule 
of fees and expenses is included in the Governance Statement and Board 
Members Report. 
■ There are no significant post-balance sheet events to report. 
■ I confirm that the Public Spending Code, suitably modified for the 
circumstances of HIQA, is being complied with. 
■ There are procedures in place for the making of protected disclosure in 
accordance with the Protected Disclosures Act 2014. A report on protected 
disclosures is included in the annual report. 
■ I confirm that Government travel policy requirements are being complied with 
in all respects. 
■ I confirm that HIQA has complied with its obligations under taxation law. 
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Chairperson’s Report
For the year ended 31 December 2019 
■  No legal action was taken by HIQA against a state agency in 2019 or and no 
state agency took action against HIQA in 2019. 
■ I confirm that the Code of Practice for the Governance of State Bodies (2016) 
has been adopted and I consider that HIQA can demonstrate full compliance 
with the Code. 
Pat O’Mahony, Chairperson Date: 22 April 2020
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Statement on Internal Control
1. Scope of responsibility 
On behalf of the Health Information and Quality Authority (HIQA), I 
acknowledge the Board’s responsibility for ensuring that an effective system 
of internal control is maintained and operated. This responsibility takes account 
of the requirements of the Code of Practice for the Governance of State 
Bodies (2016). 
2. Purpose of the system of internal control 
The system of internal control is designed to manage risk to a tolerable level 
rather than to eliminate it. The system can therefore only provide reasonable, 
and not absolute, assurance that assets are safeguarded, transactions 
authorised and properly recorded and that material errors or irregularities are 
either prevented or detected in a timely way. 
The system of  internal control,  which  accords with guidance  issued by the  
Department  of Public Expenditure and Reform, has been in place in HIQA
for the year ended 31 December 2019 and up to the date of approval of the 
financial statements. 
3. Capacity to Handle Risk 
HIQA has an Audit, Risk and Governance Committee comprising four
Board members and one external member. The Committee met six times 
during 2019. 
HIQA has outsourced its internal audit function to an independent professional 
firm which conducts a programme of work agreed with the Audit, Risk and 
Governance Committee. 
A risk management policy has been approved by the Board, which sets out 
HIQA’s risk appetite, the risk management processes in place, and the roles 
and responsibilities of staff in relation to risk. This policy has been issued to 
all staff who are expected to work within HIQA’s risk management policies, 
to alert management on emerging risks and control weaknesses, and assume 
responsibility for risks and controls within their own area of work. 
4. Risk and control framework 
HIQA has implemented a risk management system which identifies and reports 
key risks and the management actions being taken to address and, to the 
extent possible, to mitigate those risks. 
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Statement on Internal Control (continued)
A risk register is in place which identifies the key risks facing HIQA. Risks 
have been identified, evaluated and graded according to their significance, 
and are regularly reviewed and considered by the Audit, Risk and Governance 
Committee. These assessments are used to plan and allocate resources to 
ensure risks are managed to an acceptable level. 
The risk register details the controls and actions needed to mitigate risks and 
responsibility for operation of controls assigned to specific staff. I confirm that 
a control environment containing the following elements, is in place: 
■ procedures for all key business processes have been documented, 
■ financial responsibilities have been assigned at management level with 
corresponding accountability, 
■ there is an appropriate budgeting system with an annual budget which is 
kept under review by senior management, 
■ there are systems aimed at ensuring the security of the information and 
communication technology systems, 
■ there are systems in place to safeguard the assets. 
5. Ongoing monitoring and review 
Formal procedures have been established for monitoring control processes and 
any control deficiencies identified are communicated to those responsible for
taking corrective action, to management and to the Board, where relevant, in 
a timely way. I confirm that the following ongoing monitoring systems are in 
place: 
■ key risks and related controls have been identified and processes have 
been put in place to monitor the operation of those key controls and 
report any identified deficiencies, 
■ reporting arrangements have been established at all levels where 
responsibility for financial management has been assigned, and 
■ there are regular reviews by senior management of periodic and annual 
performance and financial reports which indicate performance against 
budgets and or forecasts. 
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Statement on Internal Control (continued)
6. Procurement 
I confirm that HIQA has procedures in place to ensure compliance with current 
procurement rules and guidelines and during 2019 HIQA complied with those 
procedures. 
7. Review of effectiveness 
I confirm that HIQA has procedures to monitor the effectiveness of its risk 
management and control procedures. HIQA’s monitoring and review of the 
effectiveness of the system of internal control is informed by the work of the 
internal and external auditors, the Audit, Risk and Governance Committee and 
senior management within HIQA who are responsible for the development and 
maintenance of the internal control framework. 
I confirm that the Board conducted an annual review of the effectiveness of
the internal controls for 2019. 
6. Internal control issues 
No weakness in internal control were identified in relation to 2019 that require 
disclosure in the financial statements. 
On behalf of the Board, 
Pat O’Mahony, Chairperson Date: 22 April 2020
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Governance Statement and Board Members’ Report
1. Governance 
The Board of the Health Information and Quality Authority (HIQA) was 
established under the Health Act 2007. The functions of the Board are set out 
in Section 8 of the Act. The Board is accountable to the Minister for Health and 
is responsible for ensuring good governance. The Board performs this task by
setting strategic objectives and targets and taking strategic decisions on all key
business issues. The regular day-to-day management, control and direction of
HIQA are the responsibility of the Chief Executive and the senior management 
team. 
The Chief Executive and the senior management team follow the broad 
strategic direction set by the Board, and ensure that all Board members have a 
clear understanding of the key activities and decisions related to the entity, and 
of any significant risks as they arise. The Chief Executive acts as a direct liaison 
between the Board and management of HIQA. 
2. Board responsibilities 
The work and responsibilities of the Board are set out in HIQA’s Code of
Governance which also contains the matters specifically reserved for Board 
decision. Standing items considered by the Board include: 
■ declaration of interests, 
■ reports from committees, 
■ financial reports and management accounts, 
■ performance reports, and 
■ reserved matters as arise. 
Section 35 of the Health Act 2007 requires the Board of HIQA to keep, in 
such form as may be approved by the Minister for Health with consent of the 
Minister for Public Expenditure and Reform, all proper and usual accounts of
money received and expended by it. 
In preparing these financial statements, the Board of HIQA is required to: 
■ select suitable accounting policies and apply them consistently, 
■ make judgments and estimates that are reasonable and prudent, 
■ prepare the financial statements on a going concern basis unless it is 
inappropriate to presume that it will continue in operation, and 
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Governance Statement and Board Members’ Report
(continued)
■ state whether applicable accounting standards have been followed, 
subject to any material departures disclosed and explained in the financial 
statements. 
The Board is responsible for keeping adequate accounting records which 
disclose, with reasonable accuracy at any time, its financial position and 
enables it to ensure that the financial statements comply with Section 35 of
the Health Act 2007. The Board is responsible for approving the annual plan 
and budget. Monitoring of HIQA’s performance against the annual plan and 
budget is carried out on an ongoing basis. 
The Board is also responsible for safeguarding its assets and taking reasonable 
steps for the prevention and detection of fraud and other irregularities. The 
Board considers that the financial statements of HIQA give a true and fair
view of the financial performance and the financial position of HIQA at 31 
December 2019. 
3. Board structure 
The Board consists of a Chairperson and 11 ordinary members, all of whom are 
appointed by the Minister for Health. 




Pat O’Mahony Chairperson of the Board 03/10/2018 02/10/2023 
Molly Buckley Board Member 29/07/2015 28/07/2020 
Paula Kilbane Board Member 29/07/2015 28/07/2020 
Stephen O'Flaherty Board Member 29/07/2015 28/07/2020 
Martin Sisk Board Member 29/07/2015 28/07/2020 
James Kiely Board Member 26/02/2018 25/02/2023 
Caroline Spillane Board Member 26/02/2018 25/02/2023 
Enda Connolly Board Member 26/02/2018 25/02/2023 
Lynsey Perdisatt Board Member 02/09/2019 01/09/2024 
Tony McNamara Board Member 02/09/2019 01/09/2024 
Bernadette Costello Board Member 28/02/2020 27/02/2025
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Governance Statement and Board Members’ Report
(continued)
Former Board members 




Mary Fennessy Board Member 07/04/2014 06/04/2019 
Judith Foley Board Member 07/04/2014 06/04/2019 
Deirdre Madden Board Member 26/02/2018 23/01/2019* 
* Voluntary resignation by board member
The tenure of two board members, Mary Fennessy and Judith Foley
expired on 6 April 2019. Three new board members, Lynsey Perdisatt, Tony
McNamara and Michael Rigby were appointed by the Minister for Health on 
2 September 2019. 
HIQA holds the SWiFT 3000 Governance certification from the National 
Standards Authority Ireland. The SWiFT 3000 certification is the National 
Standards Authority of Ireland (NSAI) standard for the assessment of corporate 
governance. The objective of the assessment is to assess an organisation’s 
corporate governance frameworks and specifically the level of compliance 
against relevant codes of practice, including the code of Practice for the 
Governance of State Bodies 2016 and emerging best practice. 
An external evaluation of Board performance was carried out in 2019. 
4. Committees of the Board 
The Board has established four committees, as follows: 
a) Audit Risk and Governance Committee: The role of the Audit Risk 
and Governance Committee is to support the Board in relation to its 
responsibilities for issues of risk, control and governance and associated 
assurance. The Committee is independent from the management of
the organisation. In particular the Committee ensures that the internal 
control systems including audit activities are monitored actively and 
independently. The Committee reports to the Board after each meeting, 
and formally in writing annually. An external independent person is also a 
member of the Committee. 
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Governance Statement and Board Members’ Report
(continued)
b) Resource Oversight Committee: monitors the resource requirements 
of HIQA to ensure that they are aligned with HIQA’s corporate strategy
including oversight of resource related risks. In addition, it oversees 
organisational needs and managerial performance.   
c) Regulation Committee: oversees the governance arrangements, including 
compliance and controls with regard to HIQA’s regulatory and monitoring 
functions. 
d) Standards, Information, Research and Technology Committee: oversees 
the governance arrangements, including compliance and controls, for
the functions of standards development, health information and health 
technology assessment functions. 
5. Schedule of attendance, fees and expenses for Board members 
A schedule of attendance at Board and Committee meetings in 2019 is set out 
below, including the fees and vouched expenses paid to each member: 
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Governance Statement and Board Members’ Report
(continued)
6. Disclosures required by Code of Practice for the Governance of State Bodies 
The Board is responsible for ensuring that HIQA has complied with the 
requirements of the Code of Practice for the Governance of State 
Bodies (2016).  
7. Statement of compliance 
The Board has adopted the Code of Practice for the Governance of State 
Bodies (2016). The Board believes that HIQA is compliant with the code.  








Date: 22 April 2020
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Comptroller and Auditor General Report
Report for presentation to the Houses of the Oireachtas 
Health Information and Quality Authority 
Qualified opinion on the financial statements 
I have audited the financial statements of the Health Information and Quality
Authority for the year ended 31 December 2019 as required under the provisions of
section 35 of the Health Act 2007.  The financial statements have been prepared in 
accordance with Financial Reporting Standard (FRS) 102 — The Financial Reporting 
Standard applicable in the UK and the Republic of Ireland and comprise 
■ the statement of income and expenditure and retained revenue reserves 
■ the statement of capital income and expenditure 
■ the statement of financial position 
■ the statement of cash flows and 
■ the related notes, including a summary of significant accounting policies. 
In my opinion, except for the non-compliance with the requirements of FRS 102 
in relation to retirement benefit entitlements referred to below, the financial 
statements give a true and fair view of the assets, liabilities and financial position 
of the Health Information and Quality Authority at 31 December 2019 and of its 
income and expenditure for 2019 in accordance with FRS 102. 
Basis for qualified opinion on financial statements 
In compliance with the directions of the Minister for Health, the Health Information 
and Quality Authority accounts for the costs of retirement benefit entitlements only
as they become payable.   This does not comply with FRS 102 which requires that 
the financial statements recognise the full cost of retirement benefit entitlements 
earned in the period and the accrued liability at the reporting date.  The effect of
the non-compliance on the Health Information and Quality Authority’s financial 
statements for 2019 has not been quantified. 
I conducted my audit of the financial statements in accordance with the International 
Standards on Auditing (ISAs) as promulgated by the International Organisation of
Supreme Audit Institutions.  My responsibilities under those standards are described 
in the appendix to this report.  I am independent of the Health Information and 
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Comptroller and Auditor General Report 
(continued)
Quality Authority and have fulfilled my other ethical responsibilities in accordance 
with the standards.  
I believe that the audit evidence I have obtained is sufficient and appropriate to 
provide a basis for my opinion. 
Report on information other than the financial statements, and on other matters 
The Health Information and Quality Authority has presented certain other
information together with the financial statements. This comprises the annual report, 
the chairperson’s report, the statement on internal control and the governance 
statement and board members’ report.  My responsibilities to report in relation to 
such information, and on certain other matters upon which I report by exception, are 
described in the appendix to this report. 
I have nothing to report in that regard. 
John Crean
For and on behalf of the
Comptroller and Auditor General 
24 April 2020 
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Comptroller and Auditor General Report 
(continued)
Responsibilities of Board members 
As detailed in the governance statement and Board members’ report the Board 
members are responsible for
■ the preparation of financial statements in the form prescribed under section 35 
of Health Act 2007 
■ ensuring that the financial statements give a true and fair view in accordance 
with FRS 102 
■ ensuring the regularity of transactions 
■ assessing whether the use of the going concern basis of accounting is 
appropriate, and 
■ such internal control as they determine is necessary to enable the preparation 
of financial statements that are free from material misstatement, whether due 
to fraud or error. 
Responsibilities of the Comptroller and Auditor General 
I am required under section 35 of the Health Act 2007 to audit the financial 
statements of the Health Information and Quality Authority and to report thereon to 
the Houses of the Oireachtas. 
My objective in carrying out the audit is to obtain reasonable assurance about 
whether the financial statements as a whole are free from material misstatement 
due to fraud or error. Reasonable assurance is a high level of assurance, but is not 
a guarantee that an audit conducted in accordance with the ISAs will always detect 
a material misstatement when it exists. Misstatements can arise from fraud or error
and are considered material if, individually or in the aggregate, they could reasonably
be expected to influence the economic decisions of users taken on the basis of
these financial statements. 
As part of an audit in accordance with the ISAs, I exercise professional judgment and 
maintain professional scepticism throughout the audit. In doing so, 
■ I identify and assess the risks of material misstatement of the financial 
statements whether due to fraud or error; design and perform audit 
procedures responsive to those risks; and obtain audit evidence that is 
sufficient and appropriate to provide a basis for my opinion. The risk of not 
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Comptroller and Auditor General Report 
(continued)
detecting a material misstatement resulting from fraud is higher than for
one resulting from error, as fraud may involve collusion, forgery, intentional 
omissions, misrepresentations, or the override of internal control. 
■ I obtain an understanding of internal control relevant to the audit in order to 
design audit procedures that are appropriate in the circumstances, but not 
for the purpose of expressing an opinion on the effectiveness of the internal 
controls. 
■ I evaluate the appropriateness of accounting policies used and the 
reasonableness of accounting estimates and related disclosures. 
■ I conclude on the appropriateness of the use of the going concern basis of
accounting and, based on the audit evidence obtained, on whether a material 
uncertainty exists related to events or conditions that may cast significant 
doubt on the Health Information and Quality Authority’s ability to continue as 
a going concern. If I conclude that a material uncertainty exists, I am required 
to draw attention in my report to the related disclosures in the financial 
statements or, if such disclosures are inadequate, to modify my opinion. My
conclusions are based on the audit evidence obtained up to the date of my
report. However, future events or conditions may cause the Health Information 
and Quality Authority to cease to continue as a going concern. 
■ I evaluate the overall presentation, structure and content of the financial 
statements, including the disclosures, and whether the financial statements 
represent the underlying transactions and events in a manner that achieves fair
presentation. 
I communicate with those charged with governance regarding, among other matters, 
the planned scope and timing of the audit and significant audit findings, including 
any significant deficiencies in internal control that I identify during my audit. 
Information other than the financial statements 
My opinion on the financial statements does not cover the other information 
presented with those statements, and I do not express any form of assurance 
conclusion thereon. 
In connection with my audit of the financial statements, I am required under the 
ISAs to read the other information presented and, in doing so, consider whether
the other information is materially inconsistent with the financial statements or with 
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Comptroller and Auditor General Report 
(continued)
knowledge obtained during the audit, or if it otherwise appears to be materially
misstated. If, based on the work I have performed, I conclude that there is a material 
misstatement of this other information, I am required to report that fact. 
Reporting on other matters 
My audit is conducted by reference to the special considerations which attach to 
State bodies in relation to their management and operation. I report if I identify
material matters relating to the manner in which public business has been 
conducted. 
I seek to obtain evidence about the regularity of financial transactions in the course 
of audit. I report if I identify any material instance where public money has not been 
applied for the purposes intended or where transactions did not conform to the 
authorities governing them. 
I also report by exception if, in my opinion, 
■ I have not received all the information and explanations I required for my audit, 
or 
■ the accounting records were not sufficient to permit the financial statements to 
be readily and properly audited, or 
■ the financial statements are not in agreement with the accounting records. 
99 
Annual Report 2019  |  Health Information and Quality Authority
   
   
    
    
   
   
   
   
   
   
   
   
   
   
                                 
    





          
   
  
    
   
              
   
  
    
   
Statement of Income and Expenditure and Retained 
Revenue Reserves 





Department of Health (Vote 38, E1) 15,700,000 13,200,000 
Annual and registration fees 2 7,202,745 7,210,829 
Other income 3 1,450,150 1,270,653 
24,352,895 21,681,482 
Expenditure 
Staff costs 4 18,394,752 15,943,111 
Travel and subsistence 9 864,461 808,053 
Professional fees 10 823,182 659,904 
Publication expenses 99,580 101,803 
Support costs 11 2,390,704 2,048,608 
Establishment expenses 12 1,965,164 1,850,073 
24,537,843 21,411,552 
(Deficit)/surplus for the year (184,948) 269,930 
Surplus as at 1 January 18(a) 1,316,701 1,046,771 
Surplus at 31 December 1,131,753 1,316,701 
The Statement of Income and Expenditure and Retained Revenue Reserves includes
all gains and losses recognised in the year with the exception of depreciation and
amortisation which are included in the Statement of Capital Income and Expenditure. 
The Statement of Cash Flows and Notes 1 to 21 form part of these financial statements.
On behalf of the Health Information and Quality Authority, 
Signed: Signed:
Pat O’Mahony, Chairperson Phelim Quinn, Chief Executive
Date: 22 April 2020 Date: 22 April 2020
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Statement of Capital Income and Expenditure 





Department of Health (Vote 38, L) 1,490,595 693,113 
Amortisation of Capital Fund Account 1,006,855 758,284 
2,497,450 1,451,397 
Expenditure 
Fixtures and fittings 13 15,128 71,433 
Computer equipment 13, 18(c) 1,395,717 621,460 
Non capital intangible expenditure 79,750 -
Depreciation 13 1,006,855 758,504
                        2,497,450 1,451,397 
Surplus /(Deficit)  for the Year
Opening (deficit)/surplus - -
Surplus /(Deficit)  for the Year _ _ 
The Statement of Income and Expenditure and Retained Revenue Reserves includes
all gains and losses recognised in the year with the exception of depreciation and
amortisation which are included in the Statement of Capital Income and Expenditure. 
The Statement of Cash Flows and Notes 1 to 21 form part of these financial
statements.
On behalf of the Health Information and Quality Authority, 
Signed: Signed:
Pat O’Mahony, Chairperson Phelim Quinn, Chief Executive
Date: 22 April 2020 Date: 22 April 2020
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Statement of Financial Position 
For the year ended 31 December 2019 
Notes
Fixed Assets 

















Less Current Liabilities 
Payables falling due within one year 15 (1,489,499) (1,593,264) 
Net Current Assets 1,131,753 1,316,701 
Total Assets less Current Liabilities                         2,497,450 1,451,397 
Capital and Reserves 
Revenue Reserves 18(a) 1,131,753 1,316,701 
Capital Account 16, 18(d) 2,567,845 2,163,855
                        3,699,598 3,480,556 
The Statement of Cash Flows and Notes 1 to 21 form part of these financial statements. 
On behalf of the Health Information and Quality Authority, 
Signed: Signed:
Pat O’Mahony, Chairperson Phelim Quinn, Chief Executive
Date: 22 April 2020 Date: 22 April 2020
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Statement of Cash Flows 
For the year ended 31 December 2019 





Operating Surplus (184,948) 269,930 
(Increase)/Decrease in receivables (36,833) (597,830) 
Increase /(Decrease) in payables and accruals (103,765) 67,049 
Interest received (99) (80) 
Net Cash Flow from Operating Activities (325,645) (260,931) 
Cash Flows from Investing Activities 
Purchase of fixed assets 1,410,845 692,893 
Non capital expenditure 79,750 -
Capital grants received (1,490,595) (692,893) 
Net Cash Flows from Investing Activities - -
Cash Flows from Financing Activities 
Interest received 99 80 
Net Cash Flows from Financing Activities 99 80 
Net (Decrease)/Increase in Cash and Cash Equivalents (325,546) (260,851) 
Cash and cash equivalents at 1 January 1,540,854 1,801,705 
Cash and Cash Equivalents at 31 December 1,215,308 1,540,854 
On behalf of the Health Information and Quality Authority, 
Signed: Signed:
Pat O’Mahony, Chairperson Phelim Quinn, Chief Executive
Date: 22 April 2020 Date: 22 April 2020
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Notes to the Financial Statements 
For the year ended 31 December 2019 
1. Accounting Policies 
1. (a) General Information 
The basis of accounting and significant accounting policies adopted are 
set out below. They have all been applied consistently throughout the 
year and for the preceding year.
    (b) Statement of Compliance 
The financial statements of HIQA for the year ended 31 December 2019 
have been prepared in accordance with FRS102 (the financial reporting 
standard applicable in the UK and Ireland), as modified by the directions 
of the Minister for Health in relation to superannuation. In compliance 
with the directions of the Minister for Health, HIQA accounts for the 
costs of superannuation entitlements only as they become payable 
(see (l) and (m)). This basis of accounting does not comply with FRS102, 
which requires such costs to be recognised in the year in which 
entitlement is earned.
    (c) Basis of Preparation 
The financial statements are prepared under the accruals method of
accounting and under the historical cost convention in the form approved 
by the Minister for Health with the concurrence of the Minister for Public 
Expenditure and Reform, in accordance with Section 35 of the Health 
Act 2007. 
The following accounting policies have been applied consistently in 
dealing with items which are considered material in relation to HIQA’s 
financial statements.
    (d) Income 
(i) Oireachtas grants 
The amount brought to account in the Statement of Income 
and Expenditure and Retained grants in respect of approved 
capital expenditure are accounted for in the Capital Income and 
Expenditure account on an accrual basis. 
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Notes to the Financial Statements 
For the year ended 31 December 2019 
(ii) Annual fee income 
Annual fees from providers of Designated Centres for Older
Persons are recognised three times every year in accordance 
with Statutory Instrument 245 of 2009, Health Act 2007 
(Registration of Designated Centres for Older People) Regulations 
2009 and Statutory Instrument 493 of 2013, Health Act 2007 
(Registration of Designated Centres for Older People) (Amendment) 
Regulations 2013. 
Annual fees from providers of Designated Centres for Persons with 
Disabilities are recognised three times every year in accordance with 
Statutory Instrument 366 of 2013, Health Act 2007 (Registration 
of Designated Centres for Persons (Children and Adults) with 
Disabilities) Regulation 2013. 
(iii) Application to register or vary fees 
Applications to register or vary fees are recognised on receipt of the 
relevant fee, in accordance with Statutory Instrument 245 of 2009, 
Health Act 2007 (Registration of Designated Centres for Older
People) Regulations 2009 and Statutory Instrument 366 of 2013, 
Health Act 2007 (Registration of Designated Centres for Persons 
(Children and Adults) with Disabilities) Regulation 2013. 
(iv) Other grants 
Other grants, such as EU project funded grants are recognised on 
an accrual basis.
    (e) Employee – short term benefits 
Short term benefits such as holiday pay are recognised as an expense 
in the year and benefits that are accrued at year-end are included in the 
payables figure in the Statement of Financial Position. 
    (f) Receivables 
Receivables are recognised at fair value, less a provision for doubtful 
debts. The provision for doubtful debts is a specific provision and is 
established when there is objective evidence HIQA will not be able 
to collect all amounts owed to it. All movements in the provision 
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Notes to the Financial Statements 
For the year ended 31 December 2019 
for doubtful debts are recognised in the Statement of Income and 
Expenditure and Retained Revenue Reserves. 
Annual fee debt is only written off on the basis of management 
assessment of the probability of non-collection and the cost of collection 
versus the debt outstanding. All amounts for debt written off are 
recognised in the Statement of Income and Expenditure and Retained 
Revenue Reserves.
    (g) Operating lease 
Rental expenditure under operating leases is recognised in the Statement 
of Income and Expenditure and Retained Revenue Reserves over the life 
of the lease. Expenditure is recognised on a straight line basis over the 
lease period.
    (h) Capital funding 
HIQA’s fixed assets are funded from a combination of capital grants 
and allocations from current revenue. Funding sourced from grants 
is transferred to a capital account which is amortised in line with the 
depreciation of the related assets. Capital grants in respect of approved 
expenditure are accounted for in the Capital Income and Expenditure 
Statement on an accrual basis. Expenditure funded from capital funding 
that does not result in the creation of an asset is expensed to the Capital 
Income and Expenditure Statement on an accruals basis.
     (i) Property, plant and equipment and depreciation 
Property, plant and equipment are stated at cost less accumulated 
depreciation, adjusted for any provision for impairment. Depreciation is 
provided on all property, plant and equipment at rates estimated to write 
off the cost less estimated residual value of each asset on a straight line 
basis over their estimated useful lives, as follows: 
■ Leasehold interest Life of the lease 
■ Furniture and fittings 20% 
■ Computer software and equipment 33.33% 
■ Cloud based computer software and equipment are written off over
the life of the contract 
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Notes to the Financial Statements 
For the year ended 31 December 2019 
Asset acquisitions, regardless of the source of funds, are capitalised with 
the exception of assets funded from revenue (non-capital) grants with a 
value below the following threshold: 
■ Equipment or furniture and fittings - Less than €3,809 
■ Computer software or ICT equipment - Less than €1,270 
Residual value represents the estimated amount which would currently
be obtained from disposal of an asset, after deducting the estimated 
costs of disposal, if the asset were already of an age and in the condition 
expected at the end of its useful life. 
If there is objective evidence of impairment of the value of an asset, 
an impairment loss is recognised in the Statement of Income and 
Expenditure and Retained Revenue Reserves.
     (j) Superannuation 
In accordance with Section 27 of the Health Act 2007, HIQA has 
established a superannuation scheme which has been approved by the 
Department of Health. 
The scheme is a defined benefit superannuation scheme for employees. 
No provision has been made in respect of benefits payable. Contributions 
from employees who are members of the scheme are credited to the 
Statement of Income and Expenditure and Retained Revenue Reserves 
when received. Pension payments under the scheme are charged to the 
Statement of Income and Expenditure and Retained Revenue Reserves 
when paid. By direction of the Minister for Health, no provision has been 
made in respect of benefits payable in future years.
    (k) Single public service pension scheme  
All new entrants into the public sector with effect from 1 January 2013 
are members of the single public service pension scheme, where all 
employee pension deductions are paid to the Department of Public 
Expenditure and Reform. Pension payments under the scheme are 
charged to the Statement of Income and Expenditure and Retained 
Revenue Reserves when paid. By direction of the Minister for Health, no 
provision has been made in respect of benefits payable in future years. 
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Notes to the Financial Statements 
For the year ended 31 December 2019
     (l) Critical accounting judgments and estimates  
The preparation of the financial statements requires management to 
make judgments, estimates and assumptions that affect the amounts 
reported for assets and liabilities as at the statement of financial position 
date and the amounts reported for revenues and expenses during the 
year. However, the nature of estimation means that actual outcomes 
could differ from these estimates. The following judgment has had the 
most significant effect on amounts recognised in the financial statements: 
Depreciation and residual values  
HIQA has reviewed the asset lives and associated residual values of all 
fixed assets, and in particular the useful economic life and residual values 
of fixtures and fittings, and have concluded that assets lives and residual 
values are appropriate. 
2. Annual and Registration Fee Income 
2019 2018 
€ € 
Annual fees 6,871,145 6,822,423 
Registration fees 331,600 388,406 
7,202,745 7,210,829 
3. Income 
Superannuation contributions 460,821 440,958 
EU and other grants 39,625 36,611 
Mental Health Commission 20,933 99,625 
Irish Human Rights and Equality Commission 16,000 24,273 
European Centre for Disease Prevention and Control 29,883 -
HRB grant for Collaboration in Ireland for Clinical 
Effectiveness Reviews 532,729 369,266 
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Notes to the Financial Statements 
For the year ended 31 December 2019 
National Care Experience Programme 350,000 300,000 
Interest received 99 80 
Miscellaneous income 60 (160) 
Total 1,450,150 1,270,653 
4. Staff Costs 
Wages and salaries 14,777,057 12,526,070 
Pensions 723,279 425,797 
Agency staff 1,368,745 1,733,720 
Board members’ fees 73,022 86,423 
Employers’ pay related social insurance 1,452,649 1,171,101 
Total 18,394,752 15,943,111 
Additional superannuation contributions of €585,672 (2018, €643,509) were made 
from staff salaries and remitted to the Department of Health. 
5. Remuneration 





Outstanding annual leave entitlement









The total number of staff employed, whole time equivalents, at year end was 
252 (2018, 231). 
(b)  Short-term Benefits 
Basic pay 14,477,057 12,526,070 
14,477,057 12,526,070 
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Notes to the Financial Statements 
For the year ended 31 December 2019 
c)  Key Management Personnel 
Management personnel consist of the Chief Executive, the Director of
Health Technology Assessment and Deputy Chief Executive, the Director
of Regulation, the Director of Health Information and Standards, and the 
Acting Chief Operations Officer. The total value of employee benefits for key
management personnel is set out below: 
2019 2018 
€ € 
Chief Executive Officer 157,031 151,500 
Other Key Management Personnel 492,849 473,457 
649,880 624,957 
This does not include the value of retirement benefits earned in the period. 
The Chief Executive and the other key management personnel are members 
of HIQA’s pension scheme and their entitlements in that regard do not extend 
beyond the terms of the model public service pension scheme. 
HIQA’s key management personnel were reimbursed €38,185 (2018, 
€25,912) for travel, subsistence and other expenses incurred while carrying 
out their duties. 
Details of fees earned and expenses reimbursed to members of the Board are 
set out in the Governance Statement and Board members’ Report. 
6. Employee Short-Term Benefits 
Employees’ short-term benefits in excess of €60,000 are categorised into the 
following bands: 
Employee benefits) 2019 2018 
Number Number
€  60,001 - € 70,000 65 56 
€  70,001 - € 80,000 28 26 
€  80,001 - € 90,000 14 14 
€  90,001 - €100,000 8 4 
€100,001 - €110,000 2 4 
€110,001 - €120,000 1 0 
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Notes to the Financial Statements 
For the year ended 31 December 2019 
2019 2018 
Number Number
€120,001 - €130,000 0 1 
€130,001 - €140,000 2 0 
€140,001 - €150,000 0 1 
€150,001 - €160,000 1 1 
Total employer pension contributions paid during the year was nil (2018, nil). 
For the purposes of this disclosure, short-term employee benefits in relation to 
services rendered during the reporting period include salary, overtime allowances 
and other payments made on behalf of the employee, but exclude employer’s PRSI. 
7. Hospitality Expenditure 
The Income and Expenditure and Retained Revenue Reserves Statement includes 
the following hospitality expenditure: 
2019 2018 
€ € 
External Hospitality (Note 1) 0 2,296 
Board and Staff Hospitality 1,144 924 
Total 1,144 3,220 
Note 1 Included in 2018 External Hospitality is an amount for €1,808, which was 
incurred for hosting a dinner, the cost of which was refunded in full from a grant 
from the European Network for Health Technology Assessment. 
8. Average Headcount 
2019 2018 
Regulation 169 151 
Health Technology Assessment 15 12 
Health Information and Standards 25 18 
Support staff 45 36 
254 217 
As at 31 December, HIQA employed 252 whole time equivalent staff (2018, 231). 
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Notes to the Financial Statements 
For the year ended 31 December 2019 
9. Travel and Subsistence 
2019 2018 
Domestic
Board 5,797 7,243 
Employees 809,728 768,906 
International
Employees 38,254 25,872 
External professional services* 10,682 6,032 
864,461 808,053 
Board travel and subsistence includes €3,600 paid directly to Board members (2018, 
€4,603). The balance of €2,197 (2018, €2,640) relates to expenditure paid by HIQA
on behalf of the Board members in relation to hotel accommodation. Where hotel 
accommodation was provided by HIQA, no subsistence was claimed by the Board 
member. 
*This cost relates to travel and subsistence costs which were incurred by HIQA
as part of the contractual cost associated with the receipt of certain professional 
services. 
10. Professional Fees 
Consultancy costs include the cost of external advice to management and exclude 
outsourced ‘business-as-usual’ functions. 
Consultancy 2019 2018 
€ € 
Human resources 33,302 11,255 
Governance and strategy 44,814 84,874 
Digital and data transformation strategy 160,607 -
Total consultancy 864,461 808,053 
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Notes to the Financial Statements 
For the year ended 31 December 2019 
Other professional services 2019 2018 
Legal advice 49,977 63,929 
ICT professional services 196,842 53,666 
Statutory investigations and reviews - 4,920 
Standards development and health technology
assessments 27,522 40,633 
Organisational development 119,950 123,344 
Human resources and payroll implementation  (5,982) 42,397 
Staff survey 17,158 -
Facilitation and coaching services 21,632 11,181 
External accreditations 3,229 -
Pension support services 7,893 8,610 
Procurement services 8,358 7,528 
Website review 13,776 -
Board risk and governance workshop 7,457 -
Other 2,156 6,798 
Total consultancy 469,968 363,006 
Legal Costs
Legal fees – legal proceedings (Note 1) 114,491 200,769 
Total 864,461 808,053 
Total professional fees 823,182 659,904 
Note 1 The table provides details of expenditure in the reporting period in relation 
to a range of legal proceedings. This does not include expenditure incurred in 
relation to general legal advice received by HIQA which is disclosed in other
professional services above. 
113 




   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
       
Notes to the Financial Statements 
For the year ended 31 December 2019 
Included in legal proceedings are costs related to a Judicial Review, for which party
to party costs were awarded to HIQA against the applicant. HIQA will seek to have 
these costs assessed and approved by the Taxing Master, so that the costs can be 
recovered. 
All consultancy costs incurred were charged to the Statement of Income and 
Expenditure and Retained Revenue Reserves. 
11. Support costs 
2019 2018 
€ € 
Recruitment 157,654 197,656 
Staff training and development 251,743 184,878 
Membership and subscriptions 185,911 63,312 
Telephone 132,886 113,559 
IT support and supplies (Note 18(a)) 1,475,054 1,291,665 
Internal audit and accountancy 56,725 84,041 
External audit 13,000 13,000 
Postage and stationery 96,731 87,985 
Media monitoring 11,002 8,795 
Couriers 7,618 1,696 
Prompt payment interest and charges 1,197 580 
Bank charges 1,183 1,441 
Total 2,390,704 2,048,608 
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Notes to the Financial Statements 
For the year ended 31 December 2019 
12. Establishment Expenses 
Rent 
Building service charge 
Insurance
Repairs and maintenance 
Meeting room hire
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Notes to the Financial Statements 
For the year ended 31 December 2019 
13. Fixed assets 
Cost of valuation 




Cost or valuation at
31 December 2019 
Accumulated depreciation 



















€ € € 
714,689 3,822,806 6,604,859 
15,128 1,395,717 1,410,845 
- (113,767) (113,767) 
729,817 5,104,756 7,901,937
638,305 2,802,009 4,441,004 
18,712 879,017 1,006,855 
- (113,767) (113,767) 
Accumulated depreciation
at 31 December 2019 1,109,816 657,017 3,567,259 5,334,092 
Net book value at
31 December 2019 957,548 72,800 1,537,497 2,567,845 
Restated Net book value at
31 December 2018 
(Note 18(c)) 1,066,674 76,384 1,020,797 2,163,855 
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Notes to the Financial Statements 




Annual fee receivables 305 1,405 
Prepayments 727,376 537,215 
Health Service Executive – National Patient 
Experience Survey - 300,000 
Department of Health – Capital Grants 
receivable Note 18(b) 387,905 287,288 
Project Debtors 233,753 112,915 
Payroll Receivables 25,140 74,137 
Other Receivables 31,465 56,151 
Total 1,405,944 1,369,111 
15. Payables (amounts falling due within one year) 
2019 2018 
€ € 
Payables 59,006 92,189 
Prepaid income 62,786 50,097 
Prepaid project income 3,764 17,714 
Trade accruals 763,432 897,296 
Payroll deductions 473,769 427,703 
Holiday pay accrual 126,742 108,265 
Total 1,489,499 1,593,264 
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Notes to the Financial Statements 
For the year ended 31 December 2019 




Opening balance at 1 January (Note 18 (d)) 2,163,855 2,229,246 
Movement for period
Expenditure from capital Grant 1,410,845 692,893 
Disposals (113,767) (118,683) 
Amount amortised in line with
depreciation for the period (1,006,855) (758,284) 
Accumulated depreciation on disposals 113,767 118,683 
Balance at 31 December 2,567,845 2,163,855 
17. Capital Commitments 
2019 2018 
€ € 
Contracted for 349,170 134,950 
349,170 134,950 
18. Prior Year Adjustments 
Following a review, expenditure on computer software recognised in the Income and 
Expenditure Statement in 2017 and 2018 is being reclassified as capital expenditure. 
The expenditure was approved for capital funding by the Department of Health.   
The assets are now included on the Statement of Financial Position and the 2018 
financial statements figures have been restated to reflect the reclassification.  The 
impact of this on previously reported results and balances is as follows. 
■ Expenditure charged to the Income & Expenditure account in 2017 and 2018 
is being reclassified as capital resulting in increases of €89,110 in the 2018 
reported surplus and €204,173 in retained revenue reserves at 31 December
2018. 
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■ This expenditure now charged to the Capital Income & Expenditure account is 
matched by equivalent funding from the Department of Health so there is a nil 
impact of the Capital Income & Expenditure surplus. 
■ Fixed assets at 31 December 2018 increase by €85,012 being the net book 
value of the assets capitalised and are matched by an equivalent adjustment to 
the Capital Account reserve. 
■ Receivables at 31 December 2018 increases by €204,173 representing the 
funding due from the Department of Health which was subsequently received 
in August 2019. 
a)  Restatement of Income and Expenditure Surplus and Retained Reserves
2018 Adjustment Restated 
As Previously 2018 
Reported 
2018 Surplus 180,820 89,110 269,930 
Retained Surplus at 1 January 2018 931,708 115,063 1,046,771 
Retained Surplus at 31 
December 2018 1,112,528 204,173 1,316,701 






Grants Receivable 83,115 204,173 287,288 
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For the year ended 31 December 2019 







Balance as at 1 January 2018 3,204,966 115,063 3,320,029 
Additions 532,350 89,110 621,460 
Disposals (118,683) - (118,683) 
Cost as at 31 December 2018 3,618,633 204,173 3,822,806 
Accumulated Depreciation 
Balance as at 1 January 2018
Depreciation charge for period












as at 31 December 2018 2,682,848 119,161 2,802,009 
Net Book Value 
at 31 December 2018 935,785 85,012 1,020,797 
Net Book Value 
at 1 January 2018 926,299 85,232 1,011,531 
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Notes to the Financial Statements 
For the year ended 31 December 2019 
d)  Restatement of Capital Account 
Computer Software & Equipment
2018 Adjustment Restated 
As Previously 2018 
Reported 
Balance as at 1 January 2018 2,144,014 85,232 2,229,246 
Expenditure from Capital Grant 603,783 89,110 692,893 
Amount amortised in line with 
depreciation for the period (668,954) (89,330) (758,284) 
Balance as at 31 December 2018 2,078,843 85,012 2,163,855 
19. Leasehold Commitments 
HIQA is currently occupying three leased premises (Cork, Dublin and Galway). In all 
cases the lease agreement is between the landlord and the Office of Public Works. 
The lease in respect of City Gate, Mahon, Cork was entered into in 2008 for a term 
of 20 years and one month. The annual rent payable is €370,420. As a result of
agreements entered into as part of the decentralisation programme, this rent is paid 
by The Office of Public Works and is not recouped from HIQA. 
The lease in relation to Smithfield in Dublin was entered into 2008 for a 20-year
term. The annual rent payable is €1,177,560. 
The lease in relation to Headford Road in Galway was entered into on 1 February
2016 for a 10-year term. The annual rent payable is €13,750. 
20. Board Members’ Interests 
Authority has procedures for dealing with conflicts of interest, in accordance with 
guidelines issued by the Department of Public Expenditure and Reform. 
21. Approval of financial statements 
These financial statements were approved by the Board on 22 April 2020. 
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Annual protected disclosures 
report 
This is the Health Information and Quality Authority’s annual protected disclosures 
report, as required under the Protected Disclosures Act 2014. 
The Minister for Public Expenditure and Reform has, under Section 7(2) of the 
Protected Disclosures Act 2014, prescribed the Chief Executive of the Health 
Information and Quality Authority as an appropriate recipient of disclosures of
relevant wrongdoings relating to all matters relating to the standards of safety and 
care of persons receiving health and social care services in the public and voluntary
health care sectors and social care services in the case of the private health care 
sector, as provided for by the Health Act 2007. Any such disclosures made can only
be dealt with in a way that is consistent with, and appropriate to the role, statutory
rights and duties of HIQA. 
In 2019, 210 items of concern in relation to health and social care services that 
HIQA monitors were categorised as having been received from an employee of a 
service provider. In accordance with our policy, HIQA treats these items of concern 
as potential protected disclosures. This information was logged and risk-assessed 
and in each case used to inform the most appropriate intervention by HIQA as a 
regulator of health and social care services and in compliance with its duties under
the Protected Disclosures Act 2014. One disclosure, as defined by the Protected 
Disclosures Act 2014, was made by a member of staff during 2019. The matter was 
investigated in accordance with HIQA’s policy.   
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Declaration on public service 
innovation in Ireland 
In order to better serve our people, the Irish Public Service needs to be highly
innovative. Innovation does more than simply drive economic growth. It has the 
potential to solve some of the most pressing challenges that Ireland faces now and 
in the future. 
HIQA declares to take the following actions to build a culture of innovation in our
Public Service. We will: 
Further endorse innovation as the responsibility of every public servant; 
Enable, support, inform and equip our public servants to innovate in their roles; 
Cultivate new partnerships and involve views in problem solving and designing 
and delivering our public services; 
Generate multiple options for existing and potential problems through 
exploration experimentation, iteration and testing; 
Provide insights into our experiences, best practices and lessons learned with 
other public servants in Ireland and abroad; 
Share knowledge and data with citizens in an open and transparent way. 
Innovation, experimentation and openness require constant effort and a certain 
degree of risk. 
As public servants, we must be ambitious, agile and collaborative to achieve 
meaningful and durable results. In doing so we should be open to progressive 
thinking in order to create a new and better future for all inhabitants of the State. 
To solve difficult problems, we must rely on the diversity, ingenuity and creativity of
the public and our fellow public servants. We must also be open to blue sky thinking 
in order to create a new and better future for our people. In times of considerable 
change and uncertainty, our greatest risk is refusing to take chances and try new
things. We need a culture of innovation. 
Innovation is now the benchmark in most scientific, business and social sectors. 
Embracing and enabling innovation is equally important in delivering public services 
and building inclusive, sustainable communities. 
Organisation: HIQA 
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HIQA has developed a Service Charter for the purpose of providing information to 
people engaging with our services on the level of service they can expect from us. 
The Charter sets out our commitment to engaging with our stakeholders in line with 
the principles of quality customer service for customers and clients of the public 
service. We also developed a 2019-2021 action plan, which includes specific and 
measurable targets aimed at developing and improving aspects of our interactions 
with those who engage with us for whatever purpose. 
We have published progress on implementing our Service Charter action plan in 
2019 on www.hiqa.ie. 
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Freedom of Information report 
HIQA received a total of 68 Freedom of Information (FOI) requests in 2019 and nine 
were carried over from 2018. Of this total of 77 requests, 20 were granted, 30 were 
part-granted, eight were refused, nine were handled outside of the FOI process or
withdrawn, eight were transferred to another government agency and two were 
carried over into 2020. 
All requests were responded to in accordance with the requirements of the 
Freedom of Information Act 2014. HIQA carried out refresher training for a number
of decision-makers during 2019, while a number of new decision-makers were 
appointed and also received training. 
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Over the past 12 months, HIQA has continued to work towards and has exceeded 
the targets set by Government to reduce our energy consumption by 33% by 2020. 
In conjunction with the Sustainable Energy Authority of Ireland (SEAI) and the Office 
of Public Works (OPW), HIQA has achieved a total energy saving of 34.9% on our
baseline year 2010. This achievement reflects HIQA’s commitment to reduce its 
carbon footprint and help to develop a more sustainable work environment for both 
colleagues and the community at large. We will continue to work with the SEAI and 
the OPW towards the new targets set by Government of a 50% energy reduction 
and 30% carbon reduction by 2030. 
HIQA Smithfield 
Description Electricity Gas Total 
Benchmark Year (2010) 513,114 608,769 1,121,883 
2019 343,937 370,590 714,527 
% Difference -33.0% -39.1% -36.3% 
HIQA Cork 
Description Electricity Gas Total 
Benchmark Year (2010) 215,128 0 215,128 
2019 155,859 0 155,859 
% Difference -27.6% 0.0% -27.6% 
Cork + Smithfield total benchmark year vs total last 12 months to 
December 19 No HDDCs used  
Description Electricity Gas Total 
Benchmark Year 728,242 608,769 1,337,011 
Previous 12 Months 499,796 370,590 870,386 
% Difference -31.4% -39.1% -34.9% 
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HIQA acknowledges its obligations to provide a safe working environment for all its 
employees. To achieve this we developed and maintain a robust safety management 
system which is used to identify and mitigate risks to all employees and any other
person affected by our activities. The Safety Team, which consists of our Health 
and Safety Manager, safety committee, safety representatives, fire wardens and 
first aiders have worked over the last 12 months to ensure that all activities are 
conducted in a safe manner. HIQA recorded eight accidents during 2019, none of
which were reportable under the criteria set out in the Safety Health and Welfare at 
Work Act 2005. Through our ongoing safety training programme, we will continue to 
work towards achieving an accident free working environment. 
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Complaints management  
HIQA welcomes comments, suggestions and complaints about its performance and 
conduct in the discharge of its statutory duties and responsibilities. This feedback 
may come from service providers, patients, carers, relatives, private and voluntary
organisations, statutory agencies and the general public. HIQA welcomes all 
feedback and regards complaints as opportunities to review practice, procedures 
and identify areas for improvement. We also wish to resolve complaints in an 
effective and timely manner, and use an early resolution approach to complaints 
wherever possible. 
During 2019, three complaints were received by HIQA, all of which were dealt with 
in accordance with the policy and the agreed timelines. 
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Irish Human Rights and 
Equality Commission Act 2014
The Irish Human Rights and Equality Commission Act 2014 Section 42 places 
an obligation on all public bodies to uphold the public sector duty in terms of
human rights and equality. This means that HIQA must have regard to eliminating 
discrimination, promoting equality of opportunity and treatment of its staff and the 
persons it provides services to, and protecting their human rights. 
To do this, HIQA must identify the human rights most pertinent to it, identify its 
current policies and procedures and draw up a plan to address any gaps in its 
approach to human rights and equality. HIQA must also report on its achievements 
and progress in relation to this. 
HIQA is compliant with its public sector duty under the Act. However, the 
organisation wishes to develop its human rights approach further. During 2020, 
HIQA will carry out an assessment of a number of its key functions across the 
organisation and make recommendations. It will report on its progress and 
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